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ABSTRACT

A known bidirectional relationship between intestinal microflora and the central
nervous system, coined the gut-brain-axis, has stimulated work on the association
between gut dysbiosis and inflammation, and sleep quality. Previous studies in the Hayes
Lab have reported that a high fat (HF) diet was correlated with immobile phases, a
marker of low motility during sleep found in some neurological disease and sleep
duration[1]. Long sleep duration (>1 S.D. above norms for age) is associated with poor
sleep quality or sleep fragmentation in participants who are overweight or obese
according to body mass index values[2]. The current work utilizes a reverse translational
model to propose that we can identify some of the molecular mechanisms underlying
consumption of a HF diet and sleep fragmentation. The animal model for the current
study was Danio rerio, or zebrafish. Within this Honors Thesis, an existing protocol for
Danio rerio sleep analysis was modified in order to assess the correlation between
inflammatory pathways induced via direct infection by the human fungal pathogen
Candida vs. HF diet-induced gut dysbiosis on developed measures of sleep quality[3].
Sleep analysis was administered via a Noldus DanioVision behavioral tracking device
and showed that, in 80% of replicate experimental trials (n=86), infected zebrafish larvae
exhibited increased total sleep duration, sleep % and mean sleep bout length. In 60% of
replicate experimental trials (n=68), infected zebrafish larvae exhibited a greater number
of sleep bouts, a finding consistent with sleep fragmentation defined as the number of
sleep bouts divided by the total sleep duration. Sleep analyses conducted for dietcontrolled larvae showed that zebrafish larvae administered a high fat diet exhibited an

increase in sleep bout number and larger fragmentation index, though this observation
was not found to be trending or statistically significant. Zebrafish were euthanized and
homogenized following sleep analysis in order to be used for single fish qPCR. In
Candida infected larvae, gene expression of multifunctional pyrogenic and somnogenic
cytokines TNF-ɑ and IL-6 were upregulated according to -ΔΔCt values which are
calculated as the negative difference of the ΔCt of each individual treated larvae and the
average ΔCt value of each control, non-treated larvae. Similarly, in HF diet-treated
larvae, gene expression of IL-1β and IL-6 was also elevated. Positive gene fold
expression was elevated for IL-6 in both infected and HF diet treated zebrafish. These
findings suggest that a mutual inflammatory pathway, triggered via direct infection or
diet-induced gut dysbiosis, may exist for IL-6 mediated sleep disruption.
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INTRODUCTION

Sleep Physiology and the Molecular Clock

Sleep is defined as a behavioral state consisting of immobility and depressed
responsiveness, both of which may be quickly reversed during the transition from sleep to
wakefulness[4]. While it is unclear if all animals sleep, all higher eukaryotes not only
exhibit regular sleep states, but also require sleep for proper maintenance of physiological
processes[4]. Though sleep, a homeostatic phenomenon hypothesized to result due to the
daily accumulation of adenosine primarily in the basal forebrain should not be confused
with the distinct mechanism of circadian rhythm, a physiological ‘molecular clock’ which
regulates higher eukaryotes to a 24 hour oscillatory cycle entrained to light-dark cycles
via the suprachiasmatic nucleus or SCN[5, 6]. In fact, sleep-wake regulation is often
described as a ‘two-process model’ defined by the homeostatic sleep promoting
component (process S), which accumulates due to physiological energy expenditure and
waste buildup throughout the day, and the circadian wake promoting component (process
C) which serves to consolidate sleep periods and entrain sleep-wake states to light-dark
cycles[7]. While a basic understanding of the neurophysiology underlying circadian
rhythm and subsequent observable behaviors (i.e. nighttime sleep) is critical for
understanding this project, this Honors Thesis is concerned with predicting homeostatic
sleep features based on treatment by high fat diet and direct infection.
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In humans, the foundation of the circadian rhythm (process C) begins in the SCN
which has since been deemed the ‘pacemaker’ of the circadian clock[8]. In response to
millions of years of evolutionary fine tuning, the SCN has become accustomed to daily
environmental oscillations, such as sunlight and external temperature, such that it can
regulate the body’s general metabolic and physiologic profile to match the demands of
the time of day. While the SCN and other neuroanatomical structures regulate the
molecular clock at a body-wide level, each cell within the body is home to its own set of
tightly regulated transcription factors which mediate the individual oscillations at a
molecular and tissue trophic level. The largest transcriptional contributors to this
phenomenon, and subsequently the most well understood, are Circadian Locomotor
Output Cycles Kaput, Brain and Muscle Arnt-like 1, Period, Cryptochrome, Reverse
Erythroblastosis Virus ɑ, and Retinoid-related Orphan Receptor ɑ or CLOCK, BMAL1,
PER, CRY, REV-ERBɑ, and RORɑ, respectively[9]. While the roles and regulatory
mechanisms of these genes and their encoded polypeptide products are quite intricate,
their general function in maintaining circadian oscillations can be summarized quite
simply. In short, proteins BMAL1 and CLOCK are known to dimerize and directly
upregulate transcription of both PER and CRY. Following translation, PER and CRY are
known to associate and re-enter the nucleus to then depress expression of their activators
BMAL1 and CLOCK. Moreover, REV-ERBɑ serves as a transcriptional repressor for
BMAL1 expression and RORɑ acts as a transcriptional activator[10,11]. In this manner,
the core of the cellular molecular rhythm is regulated by BMAL1 and CLOCK which are
externally regulated by REV-ERBɑ and RORɑ and internally regulated by their own
downstream targets, CRY and PER. As BMAL1 and CLOCK are intermittently activated
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and repressed, the levels of PER and CRY oligopeptides gather within the cytoplasm and
enter a complex signaling pathway resulting in melatonin production[12]. Thus, the core
set of 6 proteins described above regulate the oscillation of melatonin, a critical
somnogenic hormone, as well as a wide array of other hormone and protein
communicators not described[8].

Circadian Regulation of Metabolism, Neural Phenomena, and Immune Activity

In addition to the melatonin-mediated sleep regulatory pathways discussed above,
the cellular molecular clock system is also known to regulate general metabolic and
physiological pathways involved in recovery, regeneration, and synthesis[13,14,15].
Perhaps the most well understood role of sleep in physiological development and
restoration is the differentially observed release and fluctuation of circulating hormones.
Specifically, growth hormone release, or the pulse of most anabolic hormones (e.g.
testosterone and prolactin) for that matter, occurs during slow-wave sleep (SWS)[3]. In
addition to this, catabolic hormone release (e.g. cortisol) is depressed during sleep states.
Such restorative and growth oriented hormone release, coupled with the decreased energy
demand during sleep, lends human sleep states (i.e. the result of process S described
above in which the homeostatic driver of sleep induces immobility and depressed
responsiveness) to play a necessary role in maintenance and regeneration.
In addition to endocrine associated bodily regeneration[14], the significance of
metabolite clearance during sleep, specifically that of known neurotoxic waste product
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amyloid, is well documented. For example, Xie et al reported that cerebrospinal fluid
fluxes upregulated during sleep elevated clearance of β-amyloid, a waste product which
accumulates as a result of typical neural function during the day[15]. Conversely, a key
pathological finding of Alzheimer’s Disease is excessive buildup of β-amyloid plaques
and previous studies have shown that even Alzheimer’s Disease patients have both
elevated β-amyloid and circadian fragmentation as compared to cognitively normal
individuals[16]. Both in age-related neurodegenerative diseases and in healthy
individuals the importance of sleep in learning and memory has been extensively
studied. For example, previous studies from the Walker group indicate that a full night’s
sleep yielded elevated motor learning and, in some instances, even properly timed naps
were able to produce similar results[17]. Furthermore, related research has supported that
an increase in nighttime sleep is correlated with learning efficiency, memory
consolidation, and other neurological metrics associated with learned
performance[18,19]. Complex experimental methods have reported direct correlations
between sleep deprivation and impaired hippocampal-dependent learning suggesting that
routine quality sleep is critical for neurogenesis, memory encoding, and spatial
learning[20,21].
Most pertinent to this presented study is the interplay of the immune response and
sleep loss. Specifically, even acute sleep loss (25-50% of a single 8 hour nightly sleep
routine) has been shown to elevate basal inflammatory cytokine expression[22].
Moreover, many cytokines have been shown to hold somnogenic and pyrogenic
properties meaning that they are involved in sleep as well as the pro-inflammatory
response. The most well studied of these cytokines, tumor necrosis factor-ɑ (TNF-ɑ),
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interleukin-1β (IL-1β), and interleukin-6 (IL-6), are all generally classified as
proinflammatory proteins though differential expression of these cytokines is tightly
associated with sleep. For example, all three proinflammatory signaling molecules are
expressed at higher levels during sleep[23]. Similarly, anti-inflammatory cytokines which
serve to downregulate the pathways activated by TNF-ɑ, IL-1β, and IL-6 are upregulated
during waking states and may even perturb the transition into sleep states[23,24].
Moreover, inhibition of IL-1β has been shown to induce sleep deprivation and decreased
sleep rebound[23] and increased TNF-α expression has been linked to upregulated sleep
duration[25], especially following infection[26]. To complement these associative
findings, extensive work has been done in the field of chrono-immunology or the study of
how circadian rhythms play a reciprocal role with immune activity. One such study found
that in mutant mice strains with defective CRY genes, the repressor of BMAL1 and
activator of melatonin production described above, a more aggressive pro-inflammatory
signaling response downstream of TNF-ɑ activation was observed[27]. Finally, related
publications report that even Rev-erbɑ partial knockdown (or deficiency) perturbs the
oscillations of IL-6 production and knockdown or CRY2 upregulates the production of
IL-6[28, 29]. It is well understood that sleep, circadian rhythm, and immune activity are
mutually regulated.

Sleep and Circadian Disruption as a Drive of Disease

Sleep is necessary for proper bodily function, particularly as it pertains to
metabolic recovery, neurogenesis, and immune protection. perturbed sleep quality can
5

quickly lead to various pathological states. For example, patients with gastroesophageal
reflux disease (GERD) who become sleep deprived due to any number of social or
environmental factors have been reported to experience exacerbated pain and discomfort
GERD symptoms[30]. Previous work indicates that obstructive sleep apnea (OSA) is
known to induce, or at least worsen, hypertension[31]. Further, Porto and colleagues
(2017) reported that extreme cases of OSA can even lead to myocardial infarction [32].
Interestingly, sleep deprivation can even lead to differential immune system function in
pathological conditions. One example of this was reported by Palma and colleagues
(2006) who suggested that sleep deprivation in mice models could induce early onset
symptoms resembling the human autoimmune disease systemic lupus erythematosus[33].
Thus, disrupted sleep quality and circadian rhythm can, quite literally, cause the body to
become accustomed to dysregulated immune function and self-harming pro-inflammatory
signaling cascades. Preliminary results reported by Hayes et al.,2018, who examined the
association between sleep fragmentation (defined as the sum of percent mobile and
percent one minute immobile bouts divided by the number of immobile bouts during a
sleep interval) and mild cognitive impairment in aging adults, are consistent with
previous findings that age-related neurodegenerative diseases and both actigraphic and
self-reported sleep loss are common[34, 35].

Disease as a Driver for Disruption of Sleep and Circadian Rhythm

The observation that sleep disruption may serve as a driver for human disease is
not a unilateral phenomenon. Given that general body metabolism, neurorecovery, and
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immune regulation are reciprocally regulated by oscillatory rhythms, many disease states
are known to disrupt sleep and circadian rhythms[36, 37]. For example, previous studies
have shown that various cardiovascular disorders may lead to disrupted circadian rhythm
and associated symptoms[38]. Similarly, hypertension has been shown to dysregulate the
circadian rhythm of natriuresis[39]. Most well studied, and most pertinent to this Honors
Thesis, is the impact of age-related neurodegenerative disease on sleep and circadian
rhythm. Namely, previous studies on the pathophysiological mechanisms of Alzheimer’s
Disease (AD) as well as the clinical prodrome of AD, Mild Cognitive Impairment (MCI),
have determined that sleep and circadian rhythm disorders in MCI are common[40].
Related work has shown that aging persons with Alzheimer’s display sleep disruption
associated with elevated daytime sleepiness, elevated sleep duration, and elevated sleep
fragmentation and individuals with MCI show profound sleep disturbances[41,42,43].
Given that MCI is defined as cognitive impairment that is not severe enough to impede
daily functioning, often the earliest neuropsychiatric herald of MCI is poor nighttime
sleep especially in both amnestic and non-amnestic MCI individuals[44, 45]. In
particular, sleep fragmentation has been characterized as both a risk factor and a
diagnostic metric for MCI which, as described below, would serve as the foundation
current research conducted by Hayes[34,43].
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Alzheimer’s Disease, Mild Cognitive Impairment, and Sleep Disruption

Alzheimer's Disease (AD) composes 50-70% of dementia cases in North
America[46]. It is projected that, by 2050, the global prevalence of AD will reach 106.4
million[47]. Mild cognitive impairment (MCI), amnestic type is a precursor disease to
AD which presents as having cognitive decline which does not impede daily function
[48]. Demographic and lifestyle factors including socioeconomic status, education,
gender, and depressive symptoms have been correlated with MCI and ADRD disorders
[34]. Amnestic MCI transitions to ADRD (Alzheimer’s disease and related dementias) in
80% of cases within 6 years, developing novel methods of early detection at early stages
is needed, as less than 40% of positive cases are identied in primary care or referred to a
specialist. Sleep loss is an early sign of cognitive impairment and developing MCI in
community dwelling aging adults[40]. Holtzman et al. proposes a bidirectional
relationship between sleep continuity, particularly, stage 3 and 4 NREM, and amyloid
and tau clearance that is widely supported by human and animal model findings as a
potential mechanism for the role of sleep disorder in MCI/ADRD development[49].
Typically, diagnosing sleep fragmentation as a means of primary prevention for MCI
requires the use of an overnight clinical sleep laboratory which is uncomfortable for
aging patients, costly and often yields poor results. The Hayes Lab has developed a
patented sleep recording mattress device that can be used in the home bed for detecting
sleep-wake and respiratory patterns[34, 50].
The diagnostic utility of the sleep recording device is compared to FDA approved
actigraphy watch (Philips Respironics, Actiwatch 2). Both devices identify bodily
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movements and activity levels. Since then, computational analyses and algorithms have
been optimized to characterize not only sleep and wakefulness but various sleep
parameters including fragmentation indexes[51]. Within the context of the clinical trial,
participants were acquired either by physician referral or community recruitment events.
Each participant was then subjected to a 1 week at-home clinical sleep study consisting of
sleep analysis, neurocognitive assessment, and a wide range of exploratory statistical
analyses to elucidate other moderators of sleep quality such as dietary habits. On day 1 of
the study, participants were administered a battery of neurocognitive assessments to be
used for the physician diagnosis of neurotypical status, MCI, or AD and set up with both
the home-mattress sleep recording device as well as the aforementioned Actiwatch
positive control device. The sleep recording device and Actiwatch were picked up on
days 3 and 8 of the study, respectively, and all neurocognitive and demographic metrics
were compiled and assessed as potential moderators of any differential sleep variables
observed between neurocognitive healthy aging participants and MCI or AD participants.
It was hypothesized that greater actigraphic sleep fragmentation would be associated with
MCI and AD in aging individuals. In addition to this, a pilot study was conducted which
aimed to identify the power of dietary habits as a moderator of sleep quality. The
primary function of the novel sleep recording device is to identify early MCI/ADRD in
community dwelling adults using machine learning methods[52]. MCI-like sleep features
showed chronic sleep fragmentation due to increased frequency and duration of wake
after sleep onset, WASO), a finding supported by actigraphic findings in our sample and
consistent with the MCI/ADRD literature. The two night at-home sleep analysis included
a battery of neurocognitive assessments and sleep self-report instruments to identify
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known moderators of sleep quality which have been previously symptomatic of agerelated neurodegenerative diseases[49].

Western Diet and Sleep Quality in Aging Adults

In my Honors Thesis, I was particularly intrigued by the question of the impact of
diet on cognition and AD. The specific mechanism is discussed in further detail below
and in Figure 1 but, in brief, diet and aging have been associated with upregulated
inflammation correlated with perturbed dendritic plasticity, altered neurotransmitter
levels, and cognition[53]. As such, it is critical that more work be done to elucidate the
molecular connection between nutritional intake and potentially-pathogenic inflammatory
pathways. Specifically, little is currently known about the impact of Western Diet,
characterized by high fat and sucrose intake (e.g. pre-packaged foods and high-fat dairy
products) as well as low fiber consumption, on sleep quality in aging adults[54]. In this
Honors Thesis, a self-reported dietary survey was administered to patient’s already
undergoing an at-home sleep study in order to attempt to identify an association between
diet and MCI or AD-related sleep disruption. This pilot study was conducted on a subset
of the participant population (n=13) who were administered The Dietary Fat and Free
Sugar - Short Questionnaire (DFS)[55]. The DFS is a participant self-reported dietary
questionnaire consisting of 26 scale ranked questions. Each question on the DFS pertains
to the frequency of consuming certain foods, particularly those high in fat or free sugar.
At the end of the metric, each question, scored 1-5, can be summated to yield a total DFS
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score. Previous studies have optimized the DFS such that the total score can be used to
place participants into one of two categories[55]. Participants who score less than 60 on
the DFS are categorized as having nutritional intake within the World Health
Organization’s (WHO) recommended levels while participants who score greater than or
equal to 60 on the DFS are categorized as having fat and sugar intake above the WHO’s
recommended levels. The DFS was administered on Day 1 of the one week at-home sleep
study in order to place participants into ‘Fat and sugar intake within recommended level’
or ‘Fat and sugar intake above recommended level’ groups. It was hypothesized that
participants who were placed into the ‘Fat and sugar intake above recommended levels’
group would display perturbed sleep quality, more consistent though not necessarily
correlated with that of MCI and AD individuals than cognitively healthy individuals, as a
result of gut-dysbiosis induced inflammation. Discussed further in the Results Section,
the results of statistical analyses suggest that a diet consisting of high fat and sugar
content is correlated with a greater mean number of immobile phases and longer sleep
duration in aging adults suggesting that adults who consumed a Western Diet had more
fragmented sleep and slept for longer.

Western Diet-Induced Gut Dysbiosis and Immune Disruption

While there are extensive social factors which may have mediated the association
between poor diet and disrupted sleep quality (i.e. duration and immobility) in aging
adults, there is also evidence to support that a more complex, inflammation-mediated
11

mechanism could connect the two behaviors. In particular, this correlation could be a
result of gut dysbiosis and the gut-brain-axis.
It is estimated that, in every 1 gram sample of human gut tissue, there lives ~ 10
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bacterial cells[56]. It is well known that this bacterial population, commonly referred to
as human gut microflora, participates in extensive intracellular signalling pathways which
are necessary for human health. In particular, individuals with healthy immune systems
display a diverse gut microflora population which is critical for nutrient metabolism,
digestive health, and immune response communication[57]. Furthermore, gut microflora
have also been shown to play a key role in systemic signalling cascades which may travel
as far as the human central nervous system (CNS)[58]. Previous studies have shown that
gut microflora are involved in CNS-related protective pathways which inhibit the
symptoms of depression and anxiety[59]. Alternatively, various neurological disorders
have also been shown to negatively impact gut microbiota-involved processes such as
epithelial permeability and pathogen defense[60]. This bidirectional relationship between
human gut microflora and the brain has been coined the gut-brain-axis (GBA).
Given that the human gut microflora and central nervous system are so tightly
intertwined, it should come as no surprise that disrupting one’s microbial gut health by
consuming a poor diet can lead to damaging neurosignaling cascades. An example of this
phenomenon in mice models can be summarized in the figure below[61].
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Figure 1. Schematic depicting how Western diet induces gut dysbiosis, systemic
inflammation, and neurological pathology. (1) The mice is shown eating a cupcake,
representative of a high fat and sugar diet, which alters the typical microflora of the gut
as only select ‘good bacteria’ can survive on such poor nutritional intake and some ‘bad
bacteria’ or opportunistic pathogens invade the inhabitable epithelia. (2) As this occurs,
there is an overall change in the biochemical profile of the gut including alterations such
as depressed levels of short chain fatty acids among others. (3) As commensal bacteria
cells die, they release endotoxins stored within their lipopolysaccharide layer which are
absorbed through the intestinal epithelium, triggering an immune response. (4) As a
typical component of the acute phase response, pro-inflammatory cytokines are released
to recruit immune cells to the gut. (5) These pro-inflammatory cytokines are not guttissue trophic and can travel via the blood brain barrier to the central nervous system. (6)
Hippocampal disruption occurs, along with other general CNS disruption and
13

inflammatory signal cascade induction, which leads to a diseased state. Figure published
by Noble et al., 2017).
As described above, a key characteristic of high fat diet fed mice is depressed
levels of short chain fatty acids (SCFAs) which are produced as a byproduct of bacterial
metabolism as many commensal microbes ferment carbohydrates that cannot be digested
by host cells. These microbial produced SCFAs (e.g. butyrate) mediate development of
regulatory T cells in the gut which are necessary for mitigating intestinal inflammation.
Furthermore, these same SCFAs have been shown to bind to specific G protein coupled
receptors on the surface of neutrophils to perturb their crossing into the intestinal
epithelium which results in inflammation. As such, previous studies have shown that just
high fat diet consumption can alter gut microbe inhabitants in a manner that limits the
amount of inflammation-preventing fatty acids, thereby leading to gut-dysbiosis induced
inflammation[62]. Further, related research has found that such SCFA-mediated T cell
development may serve as the tipping point for polarization of naive T cells towards T
regulatory cells or Th1 and Th17 cells. In addition to this, SCFAs have also been shown
to inhibit pro-inflammatory markers (e.g. TNF-ɑ and IL-6) in macrophages[63]. As a
result, depressed levels of intestinal SCFAs tend to elevate pro-inflammatory cytokine
expression, elevate pathogenic T helper cell presence, and suppress T regulatory cell
presence which was found to induce central nervous system inflammatory cell
infiltration, elevate demyelination, and promote axonal damage[64].
In concordance with the hypothesized mechanism described above which explains
how a high fat diet can lead to disrupted SCFA presence, altered immune cell
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development, and disrupted CNS maintenance, related work by Lee et al., (2017) further
characterized the impact of an obesogenic diet on differential gut microbial inhabitants
and subsequent impaired gut immune health. In this study, Lee and colleagues fed mice
model groups with a normal chow diet or a high fat diet before various histological, cell
culture, and molecular methods were used to identify the putative harmful effects of a
Western diet. Beginning with the histological changes, Lee and colleagues observed that
high fat diet treated mice contained morphologically altered Paneth cells, which line the
intestinal epithelium in the small intestine and regulate commensal microbe growth via
secretion of antimicrobial peptides. Moreover, the remaining Paneth cells in high fat diet
treated mice contained less eosinophilic granules and produced less lysozyme and
procryptidin, among other antimicrobial peptides (e.g. Defcr1). Furthermore, Lee and
colleagues also identified via confocal microscopy and RT-qPCR methods that high fat
diet treated mice had less goblet cells within the interstitial epithelia and subsequently
produced less mucin, a key protein involved in the maintenance of the epithelial mucus
membrane which binds to various gut microbes in order to prevent their crossing of the
epithelial barrier. Such epithelial crossing by immune cells, as well as bacterial
lipopolysaccharide (i.e.bacterial translocation) has been further shown to upregulate proinflammatory markers such as (TNF-ɑ, IL-1, and IL-6) in the gut and other tissues (e.g.
liver and pancreas)[65]. Finally, 16s rRNA analysis identified that high fat diet treated
mice had a greater abundance of Firmicutes and Actinobacteria as well as depressed
levels of Bacteroidetes. In this manner, Lee and colleagues observed that a high fat diet
altered the intestinal epithelial cell profile, particularly in cells involved in commensal
microbe tolerance and gut immune activation, impaired the function of protective mucus
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layer-producing goblet cells, perturbed the barrier function of the gut, and directly altered
the presence and abundance of select gut microbes. As such, previous work suggested
that mice treated with a high fat diet experience gut-dysbiosis associated with altered gut
microbiota and intestinal immune health which has been known to induce altered immune
cell differentiation, epithelial barrier function, and even central nervous system
activity[66].
While the phenomenon described above of Western diet induced gut dysbiosis
links together an obesogenic diet, altered gut microbiota presence, immune activity, and
CNS function, no studies to date have defined how this mechanism may directly impair
sleep quality. The clinical observation which supported that individuals who consumed
diets high in fat and free sugar showed a greater mean number of immobile phases and
sleep duration, could be an empirical example of the phenomenon described in Figure 1
and highlighted in the studies discussed above. Thus, the human sleep data generated for
MCI and cognitively normal participants raised a question of the physiological
mechanism connecting poor diet to disturbed sleep quality in aging adults. In order to
examine this question in a tractable vertebrate experimental system, zebrafish were
selected as a model organism.
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Zebrafish as a Model Organism

Zebrafish are cyprinoid teleosts which are quickly becoming a popular model
organism for biomedical research[67]. In addition to being cheap to purchase, zebrafish
husbandry and aquarium spawning is relatively simplistic. Though they can begin eating
as early as 3 dpf, zebrafish larvae do not need to be fed for long-term survival until 4 dpf,
allowing researchers to save time and money on general maintenance and husbandry[68].
In addition to this, adult zebrafish can spawn in under 24 hours allowing for researchers
to rapidly collect fresh larvae even multiple times a day. In regards to molecular
experimental methods, as it pertains to this study, the zebrafish and human genomes
share 71.4% homology, particularly in regards to the innate and adaptive immune
system[69]. As such, zebrafish can be used as safe alternatives for genome editing
analyses in order to model human disease and pathogenesis. In addition to this, mutant
zebrafish strains with pre-determined genetic mutations (e.g. TNF-ɑ knockdown) are
commercially available. Zebrafish larvae are also naturally transparent until about 5 dpf
which is useful for various microscopy, injection, and fluorescence-based assays[67].
Thus, this model organism is perfectly suited for modeling reverse translational research
of human disease as described in this study.

Zebrafish as a Model Organism for Sleep Analysis

In mammalian species, two distinct categories of sleep have been identified:
rapid eye movement (REM) sleep and non-rapid eye movement (NREM) sleep.
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Interestingly, zebrafish and humans both share nearly identical sleep ontogeny profiles
conserved through evolution[3]. Similarly, in both humans and zebrafish, as age increases
sleep percentage decreases. With regard to other common sleep variables, including sleep
percentage, sleep bout length, sleep bout number, and fragmentation, zebrafish and
humans show similar results. However, while sleep-wake transition counts do not
necessarily decrease as humans age, they do decrease in aging zebrafish[3]. Thus,
zebrafish larvae are likely the best model for reverse translational research examining any
sleep human sleep variable as they are the most comparable in regards to overall sleep
ontogeny. Finally, much like humans, zebrafish sleep quality has been shown to be
impacted by environmental factors including temperature and light changes[70]. Thus,
zebrafish circadian rhythm can be entrained under desired lab control conditions in ways
that would not be possible with human participants, allowing for analysis of moderators
such as diet and direct infection.

Zebrafish as a Model Organism for Immune Response Analysis

As discussed above, zebrafish have become a popular model for general
biomedical research as their genomes can easily be mutated to model human disease, they
mate rapidly to produce large spawn batches, and have high genomic homology to
humans[71]. Moreover, by 4 days post fertilization (dpf), zebrafish larvae exhibit fully
robust T and B cell development which contributes to adaptive immunity[72]. Prior to
this, the innate immune response is fully developed and able to be manipulated for
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experimentation. In addition to such professional immune cells, immune signaling
cytokine messengers serve homologous functions in both humans and zebrafish.
Specifically, the pyrogenic and somnogenic cytokines most pertinent to this study, TNFɑ, IL-1β, and IL-6, are mutual between humans and zebrafish[73]. Zebrafish larvae have
been used extensively as a model organism for fungal infection analysis, including that of
Candida with previous research indicating that Candida infection upregulates TNF-α and
IL-1 production as observed in humans[74,75]. Thus, zebrafish are a suitable candidate to
model the positive control in the present study for a pro-inflammatory state induced via
Candida infection.

Zebrafish as a Model Organism for Dietary Habits and Diet-Induced Gut Dysbiosis

Zebrafish larvae can be fed as early as 3 dpf with required feeding beginning at 5
dpf[68]. The impact of various dietary profiles on zebrafish health has been extensively
studied to model human nutrition and nutritional genomics[76]. In addition to this,
following dechorionation at 1-2 dpf, zebrafish are exposed to the non-sterile environment
which mediates the development of normal gut microflora colonization as the intestinal
tract fully matures between 3-4 dpf. Thus, zebrafish have been used extensively to assess
the impact of diet on gut-dysbiosis. Previous studies by Arias-Jayo and colleagues (2018)
reported that a high fat diet induces gut microbiota dysbiosis as well as intestinal proinflammatory signaling in zebrafish larvae[77]. Moreover, previous studies have also
reported that even short-term high-fat diet exposure can induce cognitive decline in
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zebrafish, suggesting that such gut dysbiosis reported by Arias-Jayo and colleagues could
lead to pro-inflammatory signaling-mediated central nervous system disruption[78].
Thus, zebrafish are a qualified model to assess the impact of a high fat diet on dietinduced gut dysbiosis and subsequent sleep disruption in the current study. In this
Honors Thesis, it was hypothesized that zebrafish treated with a high fat diet would
exhibit gut dysbiosis-induced inflammatory gene expression resulting in sleep disruption.
The aims of this study are as follows:

1. To determine if a high fat diet induces differential sleep quality, particularly as it
pertains to fragmentation and sleep duration, in the common model organism
Danio rerio, or zebrafish.
2. To determine if direct infection by human fungal pathogen Candida albicans,
proposed as an alternative method of mimicking the putative inflammatory state
triggered by high fat consumption, induces sleep disruption in zebrafish.
3. To determine if any differential sleep quality observed in zebrafish experiencing
inflammation, be it by consumption of a high fat diet or direct infection, is
correlated with elevated pyrogenic and somnogenic cytokine expression (i.e.
TNF-ɑ, IL-1β, and IL-6). It is anticipated that Candida infection will induce
greater sleep disruption than high fat diet administration due to stronger proinflammatory cytokine signaling.
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Overview
This Honors Thesis reports a reverse-translational study which assessed the
impact of high fat diet and infection on sleep quality in zebrafish. The preliminary data
reported within this Honors Thesis pertains to results I generated in a pilot study
conducted within the MCI/ADRD ongoing study. In short, with Dr. Hayes’ assistance in
amending the parent IRB, I was able to examine the correlation between Western Diet in
MCI diagnosed participants and actigraphic sleep. In those data, sleep duration and
immobility during sleep was positively correlated with DFS measure of high fat/high
carbohydrate foods typical of the Western Diet. I hypothesized that in aging adults these
sleep features were mechanistically linked to gut-dysbiosis induced inflammatory
signaling. In order to address this hypothesis, a follow-up study was designed and
conducted in zebrafish in order to identify if pro-inflammatory cytokine expression,
induced via diet or infection, was a moderator of sleep duration and immobility. A trend
for a correlation between Candida hindbrain infection, sleep disruption, and elevated
TNF-ɑ and IL-6 gene expression was observed . Further, a trend for a correlation
between high fat diet, sleep disruption, and elevated IL-6 gene expression was observed.
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MATERIALS AND METHODS

I.

At-Home Sleep Study Experimental Model and Human Participant Details

Participant recruitment

Participants of this study were acquired via community volunteers and physiciandiagnosed MCI patients. Each participant underwent a two-day sleep study followed by a
one month follow-up neurocognitive assessment. For each sleep study, data was collected
within each participant’s home utilizing a non-invasive sleep mattress device. This device
is capable of collecting both respiration and movement data necessary to determine sleep
fragmentation. Each participant was asked to maintain their typical sleep routine for the
duration of the study. Participants within this pilot study (n=13) represent a group of
individuals taken from the larger study described above (N=95). All participant
interactions were approved by the UMaine Institutional Review Board for the Protection
of Human Subjects (IORG #: IORG0000642). See Appendix A for IRB Approval Letter.

II.

The Dietary Fat and Free Sugar - Short Questionnaire

On Day 1 of the two-day sleep study, the Dietary Fat and Free Sugar - Short
Questionnaire, or DFS, was administered to each participant and scored according to the
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protocol developed by Francis and Stevenson, 201[55]. The DFS is a self-reported dietary
questionnaire with 26 questions. The first 24 questions assess weekly intake of specific
foods (e.g. pizza or chocolate.) The last two questions assess yearly take-out food intake
and weekly free sugar intake. A copy of the DFS can be found in Appendix B. Each
question is answered numerically 1-5 with a score of 1 indicating once per week or less
and a score of 5 indicating five times per week or more. The total DFS score describes
the sum of all answers 1-26 with a minimum total score of 26 and a maximum total score
of 130. Francis and Stevenson, 2019 defined a total DFS score of 60 or greater as
indicative of a total nutrient intake above recommended levels reported by the World
Health Organization[55]. In addition to the DFS, demographic information and past
medical history were obtained for each participant as a routine component of the core
study.

III.

Actiwatch and Activas Diagnostics Sensor Actigraphy Collection

All participants were subjected to sleep analysis by the UMaine Psychology and
Engineering lab teams (PI: M. Hayes, PhD; A. Abedi, PhD) as well as a positive control
actigraphy watch (Philips Respironics, Actiwatch 2) which had been previously approved
by the American Academy of Sleep Medicine[74]. The non-invasive home sleep
monitoring system developed by the UMaine teams utilized 32 sensors to record sleep
movements and respiratory rate. In order to distinguish between brief whole-body
movements (sleep movements) and gentle, sleeping respirations (respiratory rate), the
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sleep recording system consisted of both high weight (50 lb) and low weight (1 lb)
sensors which were stacked on top of one another and adhered onto a typical cotton bed
sheet in sixteen locations, totalling at 32 embedded sensors. In addition to recording two
nights of sleep monitoring data using the UMaine sleep device, the actigraphy watch was
worn by each participant for 7 consecutive nights. Each participant was instructed to wear
the watch on their non-dominant hand at all times for the one week period aside from
showering and certain activities which may have damaged the device. As opposed to the
multi-sensor system utilized by the UMaine sleep device, the actigraphy watch coded
sleep and wake states in 1 minute epochs through an accelerometer sensor located on the
bottom of the watch. At the end of the one week period, the control actigraphy watch was
collected by the UMaine teams and sleep/wake data was analyzed by an optimized
program produced by the watch manufacturer (Philips Respironics, Philips Actiware 6:
v6 0.9).

Table 1. Human participant actigraphic variable and definitions.
Actigraphic
Variable
Time in Bed
Assumed Sleep
Actual Sleep Time
Sleep Percenta

WASO/Wake Time

Description
Time elapsed between the start and end of the rest interval
Time elapsed between the start and end of the sleep interval
The total number of epochs for the given interval scored as sleep by
Actiware multiplied by the epoch length in minutes
The percentage of epochs in an interval that are scored as sleep.
Scored total sleep time divided by (interval duration minus total
invalid time (sleep/wake)) multiplied by 100
The total number of epochs between the start time and the end time of
a given interval (sleep) scored as wake by Actiware software
multiplied by the epoch length in minutes
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Table 1 continued
Wake Percenta

Sleep Efficiency

Sleep Latency

Sleep Boutsa
Wake Boutsa
Sleep Bout Timea
Wake Bout Timea
# of Minutes
Immobile
Immobile % Time

# of Minutes Moving
Moving % Time

# of Immobile Phases
Mean Length
Immobility
1 Minute Immobility
1 Minute Immobility
%
Total Activity Score

The percentage of epochs in an interval that are scored as wake.
Scored total wake time divided by (interval duration minus total
invalid time (sleep/wake)) multiplied by 100
The percentage of time spent in bed sleep scored total sleep time
divided by (interval duration minus total invalid time (sleep/wake))
multiplied by 100
The time required for sleep to start after initiating the intent to sleep.
The time between the start of a given rest interval and the sleep
interval start time, in minutes, and is controlled by the sleep interval
detection algorithm
The total number of continuous blocks of epochs where each epoch is
scored asl sleep for the given time interval (sleep)
The total number of continuous blocks of epochs where each
consecutive epoch is scored as wake for the given interval (sleep)
The scored total sleep time divided by the number of sleep bouts for
the given interval (sleep)
The scored total wake time divided by the number of wake bouts for
the given interval (sleep)
The total number of epochs in the given interval scored as immobile
by the actiware software multiplied by the epoch length in minutes
The percentage of epochs in the given interval scored as immobile.
Scored total immobile time divided by (interval duration minutes total
invalid time (activity)) multiplied by 100
The total number of epochs for the given interval scored as mobile by
the actiware software multiplied by the epoch length in minutes
The percentage of epochs in the given interval scored as mobile.
Mobile time divide by (interval duration minus total invalid time
(activity)) multiplied by 100
The total number of continuous blocks of epochs where each epoch is
scored as immobile for the given interval
The scored total immobile time divided by the number of immobile
bouts for the given interval (sleep)
The number of immobile bouts that are one minute in length for the
given interval (sleep)
The percentage of immobile bouts that are one minute in length for
the given interval (sleep)
The sum of all valid physical activity counts for all epochs for the
given interval (sleep)
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Table 1 continued
Mean Activity Score
Fragmentation

Mean Activity/min
Std AC
Max AC
Snooze (Sleep Time)

The average of all valid physical activity counts for all epochs for the
given interval (sleep)
An index value that includes mobility and short sleep bouts. The sum
of percent mobile and percent one minute immobile bouts divided by
the number of immobile bouts for the given interval (sleep)
The average of all valid physical activity counts for all epochs for the
given interval (sleep) divided by the epoch length in minutes
The standard deviation of all valid physical activity counts for all
epochs for the given interval
The largest valid physical activity value recorded during the given
interval
The time required to become active after sleep end. The time between
the end of a given sleep interval and the end of the rest interval, and is
controlled by the sleep interval detection algorithm

Note.
a
Indicates Sleep Variable holds translational power to zebrafish larvae.
b
Indicates Sleep Variable holds translational power to zebrafish but is calculated
differently between species.
Reference. Philips Respironics Actiware (v6 0.9), Actiwatch 2tm, Respironics 2018.

IV.

Human Participant Statistical Analysis

All participant information was de-identified and entered into SPSS software
(SPSS Inc., 2007) for statistical interpretation. Participants were separated into two
groups denoted “Fat/sugar intake within recommended levels” and “High fat/sugar
intake”, according to the proposed cut-off score of a total DFS score above 60 likely
indicating nutrient intake above the World Health Organization’s recommended
levels[55]. Table 4 shows the group determination of the participants in this study. Sleep
coding and actigraphy interpretation was conducted by the engineering and graduate team
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of the Hayes Lab. Independent sample T-tests were run in order to analyze the
association between fat/sugar intake and actigraphy output.

V.

Experimental Model and Animal Subject Details

For all infection and sleep analysis experiments, AB male and female zebrafish
larvae (University of Maine, Zebrafish Facility, Orono, ME.) were used with IACUC
approval and regulations (Protocol Number: 12018-10-01, # Approved: 4825).

VI.

Zebrafish Husbandry

All zebrafish larvae were placed in solution of E3 supplemented with 0.03% of
1% methylene blue (v/v) from time of collection to 24 hpf (e.g. 50 mL E3 with 16.5 µL
of methylene blue or 150 mL E3 with 50 µL). Total larvae counts of ≤ 50 or less were
kept in 50 mL E3 and total larvae counts of ≤ 150 were kept in 150 mL E3. It should be
noted that larvae were not treated with N-Phenylthiourea to prevent melanization as the
natural pigmentation of the larvae was required for the DanioVision device to properly
track the larvae during the sleep analysis protocols described below. At 24 hpf, larvae
were transferred to 100% E3 solution of the same volume described above and
dechorionated with fine tweezers. All petri dishes containing larvae were stored at 28 ºC,
pH 7.2, with 14 hour light/10 hour dark cycles regulated by a C by GE On/Off Smart
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Plug (GE Lighting Inc.). E3 solution was replaced daily and larvae viability was assessed
via discoloration (i.e. white, cloudy appearing larvae were presumed dead and removed
from solution to be euthanized).

VII.

Zebrafish Dietary Preparation

Zebrafish dietary preparation was performed as modified from Arias-Jayo and
colleagues[72]. For control feed, 1 g of Microgemma 75 (Skretting Zebrafish, 2021.) was
dissolved in 100 mL deionized water via heated stirring. For high fat feed, 0.9 g of
Microgemma 75 and 0.1 g of pure Cocoa Butter (Mary Tylor Naturals) was dissolved in
100 mL deionized water via heated stirring. Both control and high fat feed were
autoclaved and allowed to cool before feeding periods. Feeding periods occurred once
per day at 6 pm, or the halfway point of the 10 hour light cycle. Larvae were fed 12.5 mL
of feed in 150 mL petri dishes for 10 min periods. Control and high fat designated larvae
were moved to clean petri dishes with fresh E3 following feeding periods. Between
feeding periods, the control and high fat feeds were stored at 4 ºC in a dim light.

VIII.

Zebrafish Hindbrain Ventricle Infection

Candida Culture Preparation
The following steps were conducted in collaboration with Bailey Blair. Zebrafish
hindbrain infection was performed as modified from Brothers and colleagues (Brothers et
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al, Immunology and Infection, 2012). When the to-be-infected larvae were at 1 dpf, an
overnight culture of Candida albicans SN250 (Homann et al, 2009) in 5 mL 2% YBD
media was prepared from a pre-prepared streak on LB agar plates.

Injection Preparation and Hindbrain Infection

The following steps were conducted in collaboration with Bailey Blair. The
morning prior to larvae hindbrain injection (2 dpf), 500 µL of overnight culture was
placed into a 1.5 mL microcentrifuge tube and centrifuged at max speed for 30 sec. The
supernatant was discarded and the pellet was resuspended in 500 µL of PBS. The
remaining solution was then treated with 37.5 µL of Calcofluor white stain (SigmaAldrich, #18909) and incubated at RT for 5 min. The now stained cells were then washed
three times by addition of 450 µL PBS and centrifugation at max speed for 1 min with the
supernatant discarded between steps. The stained and washed culture was then serially
diluted by pipetting 50 µL into 450 µL of PBS to a final dilution of 1 x 10-2 cells/mL.
Next, 10 µL of the final dilution was counted via hemocytometer and diluted with PBS to
a final volume of 1 x 107 cells/mL. A micropapillary injection needle was equipped with
a micropipette puller device. The needle was broken using fine tweezers to create a
shorter needle tip more optimized for hindbrain infection and to optimize the drop size of
the needle (i.e. a drop of 1 hemocytometer 1 mm x 1 mm square was preferred). The
micropapillary injection needle described above was loaded with Candida injection
culture, or PBS for control larvae, before being mounted onto a micromanipulator. At 24
hpf, the embryos were placed in an anesthetization buffer of non-lethal Tricaine (4
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mg/mL) ~10 min before hindbrain injections were completed. Anesthetized embryos
were then moved to a Petri dish with a thin layer of 1% agarose to prevent embryos from
sliding around during infection. A hair loop tool was used to orient the embryos in an
appropriate location for hindbrain injection (i.e. dorsal side facing towards the needle
tip). The needle tip was inserted into the hindbrain ventricle from this position and
injection was confirmed to be in the proper location if a rise in the general anterior
hindbrain area was observed.

Infected Zebrafish Screening

The following steps were conducted in collaboration with Bailey Blair. Candida
infected embryos were placed in 96-well plate (wells B2-G11) in E3 and analyzed via
Vivotome microscope at 10X magnification, with TL and RL Illumination On, Reflector
34 BFP, and standard Light path settings. After focusing on each fish, the fine zoom knob
was used to scan through different cuts of each embryo. Embryos with 10-25 fungal cells
(i.e. illuminated blue spheres) were kept for sleep analysis and qPCR, embryos above or
below this range were euthanized.

IX.

Zebrafish Sleep Analysis

DanioVision sleep analyses were performed as modified from Sorribes and
colleagues[3]. At 5dpf, during the last 2 h of the respective dark cycle, each zebrafish
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larvae was placed into a single well of a 12-well plate in 3 mL of E3 solution. The
covered 12-well plate was then loaded into the DanioVision device to perform sleep
analyses (Noldus Inc., . Larvae within the 12-well plate were transported within a
styrofoam box to minimize light exposure during the tail end of the dark cycle. Each
larva was then subjected to a 30 min sleep analysis within the DanioVision with a 5 min
acclimation period. The DanioVision device was pre-programmed to the following
conditions: Number of tracking sources: 1; Center-point detection (Activity analysis);
Arenas: 12. Unit of distance: cm; Unit of time: s: Unit of rotation: deg. All data collected
was directly downloaded within the EthoVision XT program (Noldus, EthoVision XT, )
and exported to Excel for further analysis as described below. Single larvae were either
euthanized following sleep analyses or prepared for single fish qPCR as described below.

X.

Zebrafish qPCR

RNA Purification

Directly following sleep analysis, the 3 mL of E3 within each larvae-containing
well of the 12-well plate was replaced with a euthanization solution (i,e.10 mL E3, 20 µL
Tris buffer (pH 9.0), 10 µL lethal Tricaine (400 g/L)) and allowed to sit at RT for 15 min.
Each euthanized larva was then individually placed in a 1.5 mL microcentrifuge tube, any
excess euthanization solution was removed and replaced with 200 µL of TRIzol reagent.
Each larva was then homogenized in TRIzol reagent by automated pestle at 7 x 3 sec
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bursts. Homogenized larvae were stored at -80 ºC for later use or the protocol was
continued as described below. If necessary, samples were thawed on ice within the hood
prior to adding 800 µL of TRIzol (total 1 mL TRIzol) then centrifuged at 12,000 x g for
15 min. The supernatant was then transferred to a screw-tap tube. Within the screw-cap
tube, an additional 1 mL of 95 % ethanol was added and vortexed. This solution was then
transferred from the screw-cap tube to a Zymo-Spin IIC Column in a collection tube prior
to being centrifuged at 12,000 x g for 1 min. Next, the solution collected within the
collection tube (flow-through) was discarded and 400 µL of RNA Wash Buffer was
added to the same spin column before being centrifuged at 12,000 x g for 1 min. The
flow-through was once again discarded and 80 µL of DNAse I cocktail (i.e. 5 µL DNAse
I, 8 µL 10X DNase I Reaction buffer, and 67 µL of DNase/RNase-Free water) was added
to the same spin column which was incubated at RT for 15 min before being centrifuged
at 12,000 x g for 30 sec. Without discarding the flow-through, 400 µL Direct-zol RNA
PreWash was added to the same spin column before being centrifuged at 12,000 x g for 1
min. The flow-through was discarded before adding 700 µL of RNA Wash Buffer to the
same spin column which was then centrifuged at 12,000 x g for 1 min. The previous step
was repeated twice (i.e. three treatments of RNA Wash Buffer in total) before the spincolumn was transferred to the final RNase-free tube. Finally, 50 µL of DNase/RNase-free
water was added to the column matrix before being centrifuged at max speed for 1 min.
The spin column was discarded and the eluted RNA was quantified then either stored at 80 ºC or used immediately for cDNA preparation. RNA stocks were quantified via a preprogrammed ND1000 Nanodrop Nucleic Acid Program. The nanodrop device was
blanked with 2 µL of nuclease free water before quantifying 2 µL of each single-fish
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RNA stock. RNA stocks with 260/280 values of ~1.8-2, 260/230 values of ~2-2.2, and
total concentrations of 60 ng/µL were deemed acceptable for further cDNA preparation.

cDNA Preparation

Following RNA quantification, stored samples were either thawed on ice or
directly added to a reaction recipe (i.e. 4 µL of 5X reaction buffer, 500 ng RNA stock,
made up to a total volume of 20 µL using nuclease free water). The volume of RNA
stock necessary to make 500 ng was determined by dividing 500 ng by the RNA
concentration determined in the previous section. The volume of nuclease free water
necessary for the recipe was determined by subtracting the volume of RNA stock being
added from 15 mL. The complete reaction recipe was moved to thermocycler tubes
before being treated by a standard thermocycler program. Directly after the thermocycler
program was completed, 40 µL of nuclease-free water was added into each reaction
recipe-containing thermocycler tube and either stored at -20 ºC or used immediately for
qPCR analysis.

qPCR

BioRad SSOSyber Green Supermix (BioRad, #170-8880).was used to perform all
qPCR analysis. Following cDNA preparation, stored samples were either thawed on ice
or added directly to the qPCR reaction recipe (i.e. 5 µL of Sybr Green, 0.15 µL of
forward primer, 0.15 µL of reverse primer, 1.7 µL of nuclease free water, and 3 µL of 3:1
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diluted cDNA). For large sample sizes, a master mix of Sybr Green, forward primer,
reverse primer, and nuclease free water was added to each qPCR plate via a multichannel pipettor before adding each diluted cDNA sample individually to each well. Each
cDNA sample was assessed in duplicate with a no-DNA template included for each gene
being assessed. Each qPCR plate was covered with a clear plastic seal before being
centrifuged at 5,000 rpm for ~2 sec. The qPCR plate was then treated by the preprogrammed standard thermocycler program.

XI.

Zebrafish Sleep Coding

Downloaded EthoVision XT data exported to Excel was first parsed to only
include Time (s) and Velocity (cm/s) before being further reduced into 1 s bins (standard
EthoVision XT outputs are in 1/30th sec bins). The threshold value for immobility of 0.5
cm/s was then implemented by the equation =IF(B:B>0.5,1,0), where column B indicates
the velocity column, such that any 1-sec velocity output greater than 0.5 cm/s was coded
as a 1, or mobile, and any 1-sec velocity output less than 0.5 cm/s was coded as a 0. After
six consecutive 0s in the binary code, the seventh 0 and any after were coded as sleep.
Any 1 that interrupted a string of 0s, or sleep bout, was then coded as the start of a wake
bout. The total sleep duration was determined using the equation =COUNTIF(D:D, “S”),
where column D indicates the sleep coding column of “S” or “W” for sleep versus wake
states. The number of sleep bouts was determined by counting the number of strings of
“S” in column D. For ease of counting sleep bouts, all wake bouts were filtered and
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highlighted in green and all sleep bouts were filtered and highlighted in purple. To
calculate the mean sleep bout length, the total sleep duration was divided by the number
of sleep bouts. To calculate the fragmentation index, the number of sleep bouts was
divided by the total sleep duration. The Sleep % was determined by dividing the total
sleep duration by the sum of the total wake duration and total sleep duration. Total wake
duration was determined using the equation =COUNTIF(D:D,”W”). The number of wake
bouts was determined by counting the number of strings of “W” in column D. The mean
wake bout length was calculated by dividing the total wake duration by the number of
wake bouts. The Wake % was calculated by dividing the total wake duration by the sum
of the total wake duration and total sleep duration. All sleep variables were converted to
minute units before conducting statistical analyses.
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Figure 2. Schematic of the experimental workflow for zebrafish larvae reverse
translational analysis. (A1) Infected group larvae were injected with C. albicans SN250
culture or mock PBS solution at 1 dpf. (A2) Dietary group larvae were fed high-fat diet
or typical commercial flake food starting at 3 dpf. (B) All zebrafish larvae were subjected
to 35 min sleep analysis intervals at 5 dpf. (C) All zebrafish larvae were euthanized,
homogenized, and used for single fish qPCR immediately after sleep analysis.
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Table 2. Translational experimental components for human participants and
zebrafish larvae.

Humans

Dietary Analysis

Sleep Analysis

Dietary intake was not
controlled in human
participants. Experimental
groups (i.e. Fat and sugar
intake within recommended
levels, Fat and sugar intake
above recommended levels)
were determined using the
Dietary Fat and Free Sugar Short Questionnaire.

All human participants
were administered a 7 day
home sleep study. All
participants slept on the
UMaine lab teams sleep
recording system for 2
nights. All participants
also wore an actigraphy
watch for 7 days to serve
as a positive control for
the novel at-home sleep
system.
All zebrafish larvae were
subjected to a 35 minute
interval sleep analysis
utilizing a Noldus
DanioVision device at 5
dpf.

Zebrafish Zebrafish larvae dietary
intake was controlled.
Zebrafish were placed into
control groups and high fat
groups starting at 3 dpf.
Control groups were fed
typical commercial flake
food. High fat groups were
fed typical commercial flake
food supplemented with
100% cocoa butter.
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Inflammasome
Analysis
Human
inflammasome
gene expression
was not
analyzed during
the 2019 athome sleep
study.

To assess the
hypothesis that
diet-induced gut
dysbiosis
induced poor
sleep quality
mediated by
inflammasome
gene expression,
each zebrafish
larvae was used
for single fish
qPCR following
Noldus
DanioVision
sleep analysis.

XII.

Zebrafish Statistical Analysis

For statistical analysis, calculations were conducted in Excel (Microsoft
Corporation, 2018), R (R Foundation for Statistical Computing, Vienna, Austria, 2017),
or GraphPad Prism (La Jolla, CA, USA, 2020) using Shapiro-Wilke test to confirm
normality and Student’s t-test to assess for variation between experimental and control
groups. For qPCR analysis, the ΔΔCt value of each group (e.g. control vs. infected,
healthy diet vs. high fat diet) was compared using Mann-Whitney test. All plots represent
mean +/- standard deviation. For all figures, *p<0.05. **p<0.01. ***p<0.001.
****p<0.0001.
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RESULTS
I.

At-Home Sleep Study Demographics

Table 3. Demographics of nutrient intake within recommended levels and high
fat/sugar intake groups

Variable
(µ±SE or % (n))
Age, y
Female
Years of education
Montreal Cognitive Assessment
(MoCA)
Lifestyle factors

Fat/sugar
intake within
recommended
levels
(n = 8)
71.31±0.91
77.78%
15.60±0.35
26.73±0.30

High
fat/sugar
intake
(n = 5)

p-value

74.28±0.95
100.00%
15.34±0.45
21.54±0.45

n.s.
n.s.
0.069
n.s.

Drinking alcohol
62.2%
56.3%
n.s.
Current or former smoker
46.7%
54.2%
0.071
Current use of sleep
42.2%
41.7%
n.s.
a
medication
Body mass index (BMI)
27.60±0.86
28.03±0.92
n.s.
Obstructive sleep apnea (OSA)
17.8%
28.0%
n.s.
Diabetes
11.1%
20.8%
n.s.
Heart attack or cardiac arrest
11.1%
14.6%
n.s.
Cardiovascular disease
13.3%
18.8%
n.s.
Cerebrovascular disease
6.7%
16.7%
n.s.
Traumatic brain injury (TBI)
15.6%
18.8%
n.s.
Hypercholesterolemia
42.2%
41.7%
n.s.
Hypertension
34.1%
47.9%
n.s.
Arthritis
47.7%
55.4%
n.s.
Thyroid disease
33.3 %
25.0%
n.s.
a
Current depressed mood
13.3%
37.5%
n.s.
Note: Values are shown as % or mean ± SE, and compared by independent samples t-test
(continuous variables) or chi-square test of association (categorical variables).
a

Current use of sleep medication was described as any self-reported use of over the
counter or prescribed sleep medication over the last month
b

Current depression was indicated by self-report answering the question “Are you
currently feeling depressed?”
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In regards to the participant's initial demographic screening, a trend for an
association between years of education and fat/sugar intake within recommended levels
was observed. Furthermore, a trend for being a current or former smoker and high
fat/sugar intake was observed. Finally, it should be noted that all of the participants
enrolled in my pilot study who were placed into the high fat/sugar intake group were
female. While these demographic characteristics are not directly applicable to the
hypothesis of my study, they do provide notable insight into the lifestyle choices and
social determinants of health pertaining to the participants enrolled in this pilot study.

II.

Dietary Fat and Free Sugar - Short Questionnaire Self Reported Values

Table 4. Saturated fat and free sugar intake scores according to the Dietary Fat and
Free Sugar - Short Questionnaire
Participant ID
Saturated fat and free sugar intake scores
096
59
097
71*
098
47
099
36
100
23
101
66*
102
50
103
50
104
78*
105
50
106
70*
107
74*
109
51
Note. *Participant’s saturated fat and free sugar intake likely exceeds recommended
levels.
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Sleep fragmentation is both a risk factor for and a symptom of Mild Cognitive
Impairment, the clinical prodrome of Alzheimer’s Disease. As such, the development of
early identification diagnostic tools for sleep fragmentation and other disrupted sleep
patterns could help in preventing the progression of MCI into AD, an agenda which is of
particular importance for Maine’s aging population. Starting in 2015, the Hayes Lab
conducted a study which optimized a sensor-embedded mattress device capable of
diagnosing MCI through one’s sleep quality within a participant’s home environment.
The objective of this device was to provide a more accessible and affordable option for
aging individuals to assess their sleep quality, especially for those who had family history
of sleep disorders and age-related neurodegenerative disorders, in order to mitigate one’s
risk of developing MCI, AD, and related forms of dementia. As is the case with many
lifestyle factors, sleep can be impacted by countless factors including dietary choices. For
this reason, the nutritional profile of each participant enrolled in the at-home sleep study
was assessed by administering the Dietary Fat and Free Sugar - Short Questionnaire
(DFS) in order to analyze the power of diet as a moderator of sleep quality and related
neuropathology. The DFS is a 26 question self-reported survey in which individuals are
asked to self-rank the frequency of how often they consume certain foods, particularly
those high in fat and sugar content. Each question is scored 1-5 and the overall survey is
summated. Those who score ≥60 or greater on the DFS are likely consuming a diet of fat
and sugar above the WHO’s recommended levels.
Within the context of the ongoing clinical study, each participant was
administered the DFS on Day 1, prior to any sleep analysis. The results of the total
summated DFS scores for all participants (n=13) are shown in Table 2. Five of the
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thirteen participants (38.46%) scored equal to or greater than 60 on the DFS, indicating
that their fat and free sugar intake was above the WHO’s recommended levels. These five
participants were placed into the ‘High fat/sugar intake’ group while the remaining eight
participants were placed into the ‘Fat/sugar intake within recommended levels group’. At
the end of the one week study, these two groups were assessed as potential moderators of
each sleep variable recorded by the novel sleep recording device. As indicated in Table 3
below, Independent sample T-tests were run in order to analyze the association between
fat/sugar intake and actigraphy output. The sleep metrics described in this pilot study
were interpreted by actigraph, an accompanying measure to the novel sleep recording
device (1014). Sleep time was different between groups and strongly increased in the diet
risk group. Group findings show that “Fat/sugar intake within recommended levels”
(M=5.78, SD=2.45) and “High fat/sugar intake” (M=14.79, SD=4.62) conditions were
statistically different, t(11)=-4.66, p = 0.001, revealing greater sleep duration in the High
fat/sugar intake group. There was a trend for the association in the scores for immobility
during sleep measured by the mean number of immobile phases between the “Fat/sugar
intake within recommended levels”group (M=37.13, SD=8.06) and “High fat/sugar
intake”group (M=52.44, SD=20.41) conditions; t(11=-2.01, p = 0.070). As shown in
Table 4, actigraphy findings suggest that poor diet increased sleep duration, a companion
marker of sleep loss, and disrupted motor activity during sleep, measured by more
transitions from mobile to immobile activity levels, which is consistent with increased
sleep to wake state events and sleep fragmentation.
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III.

Human Participant Sleep Variables

Table 5. Actigraphy variables for fat/sugar intake within recommended levels and
high fat/sugar intake groups
Variable

Mean Time in Bed
Mean Assumed Sleep
Mean Actual Sleep
Time
Mean Actual Sleep %
Mean Actual Wake
Time
Mean Actual Wake
%
Mean Sleep
Efficiency
Mean Sleep Latency
Mean Sleep Bouts
Mean Wake Bouts
Mean Mean Sleep
Bout Time
Mean Mean Wake
Bout Time
Mean Number of
Minutes Immobile
Mean Immobile %
Time
Mean Number of
Minutes Moving
Mean Moving %
Time
Mean Number of
Immobile Phases

Fat/sugar intake
within
recommended levels
(n=8)
519.67±28.70
499.77±26.81
443.79±30.16

High fat/sugar
intake
(n=5)

p-value

524.72± 47.50
489.86±45.91
420.21±42.88

n.s.
n.s.
n.s.

88.59±1.92
55.76±7.37

85.90±3.77
69.54±18.46

n.s.
n.s.

11.41±1.92

14.12±3.77

n.s.

85.17±1.77

79.85± 2.72

n.s.

14.12±4.19
21.71±2.24
21.15±2.20
23.84±3.27

20.07±4.79
26.97±4.83
26.50±4.90
17.84±3.12

n.s.
n.s.
n.s.
n.s.

2.68±0.36

2.68±0.65

n.s.

428.41±27.69

384.25±41.77

n.s.

85.68±1.89

78.76±5.73

n.s.

71.29±7.92

105.57±27.84

n.s.

14.32±1.89

21.19±5.76

n.s.

37.13±2.69

52.44±10.21

0.070
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Table 5 continued
Mean Mean Length
12.47±1.07
9.16±2.47
n.s.
Immobility
Mean One Minute
7.44±1.25
13.29±3.96
n.s.
Immobility
Mean One Minute
18.16±1.84
22.62±5.69
n.s.
Immobility %
Mean Total Activity
8282.05±1418.17
9445.93±2764.52
n.s.
Score
Mean Fragmentation 32.48±3.74
43.85±11.40
n.s.
Index
Sleep Time
5.78±0.82
14.79±2.31
0.001
Note. x ± y represents the mean ± standard error of the mean (SEM), (n) = sample size.
Note. x ± y represents the mean ± standard error of the mean (SEM), (n) = sample size.

The results reported of the at-home sleep study stimulated the idea for a reversetranslational follow-up study which aimed to further elucidate the putative molecular and
physiological mechanism connecting Western Diet to perturbed sleep quality. It was
hypothesized that Western Diet, a known inducer of gut dysbiosis and systemic
inflammation, triggered pro-inflammatory signaling pathways involving pyrogenic and
somnogenic cytokines which caused the observable sleep disruption. In order to assess
the above hypothesis, zebrafish were selected as a model organism given that they have
comparable sleep ontogeny to humans as well as a highly homologous immune system. It
was hypothesized that zebrafish who were experiencing systemic inflammation would
produce greater immune gene expression of inflammatory cytokines with both pyrogenic
and somnogenic effects. In addition to this, it was hypothesized that such differential
cytokine gene expression would serve as a moderator for perturbed sleep quality in
zebrafish larvae. Inflammation was induced in zebrafish larvae by direct infection with
human fungal pathogen Candida, meant to serve as a strong inflammatory response
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positive control, or by a high fat diet, meant to serve as an experimental model for the
Western Diet consumed by human participants in the initial sleep study. Respective
controls for each method of inflammation were also incorporated (i.e. half of the infected
group was injected with a mock-PBS solution and half of the dietary group was fed
normal commercial flake food). Following inflammation induction, as elicited via
pathogen infection or a high fat diet, each zebrafish larva was subjected to a 35 minute
sleep analysis within the last hour of their 14 hour dark cycle and subsequently
euthanized for single fish qPCR analysis. This overall experimental workflow was
repeated such that the 6 replicate sleep analysis trials and 2 replicate qPCR analyses were
conducted for the infected group and 4 replicate sleep trials and 2 replicate qPCR
analyses were conducted for the dietary group. However, only 1 of the sleep trials
performed for the dietary group was used for data analysis due to experimental error
involving file export within the Noldus EthoVision XT program. The results of both the
infected zebrafish group and the high fat diet zebrafish group are discussed extensively
below.
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IV.

Infected Zebrafish Sleep Analysis

Figure 3. Total sleep and wake duration (minutes) and sleep and wake % for Mock
PBS Injected and Active Candida Infection zebrafish larvae in repeat sleep analysis
Trials 1-6. (A) Total Sleep Duration of control and infected zebrafish. (B) Total wake
duration of control and infected zebrafish larvae. Though not shown here, sleep and wake
% depicted identical results to total sleep and wake duration. Bar plots and error bars
represent Mean and SD. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001.

All sleep variables analyzed in zebrafish larvae were selected on previous
optimization and proof-of-concept analyses as well as reverse-translational power to
human actigraphy variables. Zebrafish larvae sleep analyses were conducted at 35 min
intervals within the last hour of the assigned 14-hour dark cycle. Zebrafish sleep analysis
is distinct from humans in that measures pertaining to time spent ‘in bed’ (e.g. Sleep
Latency) cannot accurately be assessed. However, total sleep and wake duration and
percentage (Figure 3) as well as the number of sleep and wake bouts, mean length of
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sleep and wake bouts, and fragmentation indexes (Figure 4) are mutual sleep variables
which have been reported in both humans and zebrafish. Thus, in the place of actigraphy
sensors, zebrafish immobility and velocity states can be used to predict sleep and
wakefulness as well as the transition between these two states. As observed in Figure 3
above, sleep variables are highly irregular between identical repeat experiments as well
as within some experimental groups. This observation could serve to explain the absence
of a statistically significant difference between each sleep variable in the Active Candida
Infection group (n=56) and the Mock PBS Injection group (n=55) data sets (Appendix
C). However, statistically significant observations can still be used to assess trending
results between experiments.
For all zebrafish sleep variables, sample normality was assessed by Shapiro-Wilk
test and independent variables were assessed by Student’s t-test. In 80% of infected
zebrafish sleep analyses, the Active Candida Infection group exhibited a greater total
sleep duration and sleep %, and subsequently a lower Total Wake Duration and Wake %,
than the Mock PBS Injection group. Moreover, Trials 1, 2, and 5 exhibited statistically
significant variation in these sleep parameters (Trial 1: n=20, p=0.01831.Trial 2: n=22,
p=0.012241. Trial 5: n=22, p=0.000173).
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Figure 4. Number of sleep and wake bouts, mean sleep and wake bout length
(minutes), and fragmentation indexes for PBS injected and active Candida infection
zebrafish larvae in repeat sleep analysis Trials 1-6. (A) Total Sleep Duration of control
and infected zebrafish. (B) Total wake duration of control and infected zebrafish larvae.
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(C) Sleep % of control and infected zebrafish larvae. (D) Wake % of control and
zebrafish larvae. Bar plots and error bars represent Mean and SD. *p<0.05. **p<0.01.
***p<0.001. ****p<0.0001.

In 60% of infected zebrafish sleep analyses the Active Candida Infection group
exhibited a greater number of sleep bouts than the Mock PBS Injection though only Trial
5 yielded statistically significant results (Trial 5: n=22, p=0.00135). Similarly, in 80% of
infected zebrafish sleep analysis the Active Candida Infection group exhibited a greater
mean sleep bout length than the Mock PBS Injection group though only the results of
Trial 1 were statistically significant (Trial 1: n=20, p=0.005955). Regardless of sleep bout
length, by definition the end of each sleep bout must simultaneously signal the beginning
of a wake bout. Thus, larvae who had a higher Number of Sleep Bouts also yielded a
higher number of wakebBouts. While this may not appear to add obvious information for
analysis, wake variables are an integral part of human sleep analysis and, thus, should be
included for zebrafish sleep studies to maintain reverse translational power. Such
characteristic brief, intermittent arousals in zebrafish larval sleep was further quantified
by the fragmentation index. Specifically, in 60% of infected zebrafish sleep analyses the
Active Candida Infection group exhibited a lower fragmentation index than the Mock
PBS Injection group with both Trials 1 and 2 yielding statistically significant results
(Trial 1: n=20, p=0.009936, Trial 2: n=22, p=0.021788). The results reported in Figures 3
and 4 indicate that zebrafish experiencing inflammation induced via direct pathogen
infection tend to have more frequent sleep bouts (i.e. periods of immobility), longer sleep
bouts, and overall exhibit greater sleep duration than zebrafish who are not infected.
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V.

High Fat Diet Zebrafish Sleep Analysis

The results of the infected zebrafish sleep analysis are not inconsistent with the
hypothesis that zebrafish larvae experiencing strong inflammation induced by fungal
pathogen Candida exhibit perturbed sleep quality, particularly in regards to sleep
duration and the number and length of sleep bouts (Figures 3, 4). As such, given that the
infected zebrafish group was meant to serve as a positive control for the putative
inflammatory pathways hypothesized to be triggered by a high fat diet, further
experimentation was done to assess the power of a high fat diet as a moderator of sleep
quality in zebrafish.
Beginning at 3dpf, following manual dechorionation at 2 dpf and expected
development of a functioning digestive tract occurring as early as 3 dpf, zebrafish larvae
were split into ‘Control Diet’ and ‘High Fat Diet’ groups. The Control Diet was prepared
by suspending 1 g of Gemma 75 commercial flake food (Skretting Zebrafish, 2021.) in
100 mL of deionized water. The High Fat Diet was prepared under similar conditions but
was supplemented with 10% (w/w) pure cocoa butter mixed via heated stirring. Both
feeds were autoclaved and allowed to cool at room temperature prior to feeding in order
to mitigate the risk of bacterial colonization of the feed prior to consumption as this
would induce non-high fat diet-mediated gut microflora shift and potentially
inflammatory signaling. Identical statistical analyses were performed on the high fat
zebrafish group. As was observed in the infected zebrafish group, diet-controlled
zebrafish displayed highly variable sleep metrics between identical repeat experiments.
The results of the high fat zebrafish sleep analysis are discussed extensively below.
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Figure 5. Total sleep and wake duration (minutes) in control diet and high fat diet
zebrafish larvae in repeat sleep analysis Trials 1-6. (A) Total Sleep Duration of control
and high fat fed zebrafish. (B) Total wake duration of control and high fat fed zebrafish
larvae. Though not shown, sleep and wake % depict identical results to total sleep and
wake duration. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001.

Though no values were found to be statistically significant, the results in Figure 5
report that High Fat fed zebrafish generally exhibited depressed total sleep duration and
sleep % and subsequently a greater total wake Duration and Wake %. Though any lack of
statistical significance could be due to uneven control and experimental groups as well as
a small sample size. Similarly, as shown in Figure 6 below, high fat fed zebrafish had a
greater number of sleep bouts and shorter mean sleep bout lengths than control diet fed
zebrafish. Furthermore, high fat fed zebrafish exhibited a greater fragmentation index
than control diet fed zebrafish. Future research should repeat this experiment to produce a
larger sample size in order to account for natural variability in zebrafish larvae sleep
analyses and to highlight any potentially unobserved trends in differential sleep quality.
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Figure 6. Number of sleep and wake bouts, mean sleep and wake bout length
(minutes), and fragmentation indexes for control diet and high fat diet zebrafish
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larvae in repeat sleep analysis Trials 1-6. (A) Total sleep duration of control and high
fat fed zebrafish. (B) Total wake duration of control and high fat zebrafish larvae. (C)
Sleep % of control and high fat fed zebrafish larvae. (D) Wake % of control and high fat
fed zebrafish larvae. Bar plots and error bars represent Mean and SD. *p<0.05. **p<0.01.
***p<0.001. ****p<0.0001.

While statistically significantly differential sleep quality was observed in Candida
infected zebrafish larvae, and non-significant differences were observed in high fat fed
zebrafish larvae, these associative observations were not sufficient to address the entire
aim of this study. Namely, single fish qPCR experimentation was necessary to elucidate
if elevated somnogenic and pyrogenic cytokine expression mediated perturbed sleep
quality in either group. In order to accomplish this, directly following sleep analysis each
larvae was euthanized, homogenized, and stored at -80 ºC for future use in quantitative
real time PCR (qPCR).

VI. Infected Zebrafish qPCR Analysis
As with any qPCR experimental design, it was critical that proper target genes
were selected for analysis in order to accurately address the hypothesis that proinflammatory cytokines served to induce sleep disruption in both Candida infected and
high fat fed zebrafish. As such, TNF-ɑ, IL-1β, and IL-6 were assessed in both zebrafish
experimental groups as, to date, these signaling molecules are the most comprehensively
understood cytokines known to regulate both the pro-inflammatory response and sleep
state behaviors (Kreuger, 1989).
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Figure 7. Gene expression of TNF-ɑ (Blue) and IL-6 (Green) is upregulated (n.s.) in
Candida infected zebrafish larvae. Il-1β (Red) is depressed (n.s.) in Candida infected
zebrafish larvae. (A) qPCR Trial 1. (B) qPCR repeat Trial 2. (C) Pooled ΔΔCt of Trial 1
and 2. Bar plots and error bars represent Mean and SD. Ct values correspond to initial
qPCR Cycle threshold output values. ΔCt values indicate the difference between target
and non-target gene expression. ΔΔCt values indicate the difference between single
Candida infected larvae ΔCt values and the average ΔCt value of control larvae. Thus, ΔΔCt values represent the direction of fold change in gene expression.

qPCR Real-Time Systems produce cycle threshold (Ct) values which are
inversely proportional to the levels of targeted mRNA in the provided sample. Though Ct
values serve as necessary intermediates in any qPCR analysis, they do not provide
meaningful quantitative data which can easily be interpreted. As such, ΔCt, ΔΔCt, and
even fold change expressions are commonly calculated. Of the three, ΔCt values are the
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only metric which maintain the identity of a single zebrafish larvae’s gene expression.
ΔCt values are calculated by subtracting the housekeeping gene (i.e. GAPDH) expression
of a particular larvae from the target gene expression of a particular larvae. As such, ΔCt
values serve to show the difference between target and control, baseline samples. Further,
ΔΔCt serves to explain the difference between a treated and untreated sample. ΔΔCt
values are calculated by subtracting the average ΔCt of a control larvae from the ΔCt of
an individual experimental larvae. In this manner, ΔΔCt values indicate differential
expression induced by the experimental moderator. Given that gene expression fold
change can be calculated by the negative log base two of ΔΔCt values, a negative ΔΔCt
value is indicative of elevated gene expression and a positive ΔΔCt is indicative of
depressed gene expression when comparing the treated group to the control group. Or, as
seen in Appendix F, infected larvae who exhibit a negative ΔΔCt value for a target
cytokine produce fold change values above 1 indicative of elevated gene expression
while infected larvae who exhibit a positive ΔΔCt value produce fold change values
below 1 indicative of depressed gene expression. In Figure 7 above, it can be seen that in
both Trial 1, Trial 2, and the pooled data set for infected larvae zebrafish, TNF-ɑ and IL6 both have negative ΔΔCt values while IL-1β has a positive ΔΔCt value. Thus, the
experimental replicate results suggest that direct Candida infection serves to upregulate
TNF-ɑ and IL-6 gene expression while down regulating IL-1β expression.

55

VII. High Fat Diet Zebrafish qPCR Analysis
As discussed above, the strong positive control for pro-inflammatory and
somnogenic cytokine release, direct Candida infection, was shown to be correlated with
perturbed sleep quality and elevated expression of cytokines TNF-ɑ and IL-6. These
results incited investigation into the hypothesized mechanism of high fat-mediated gut
dysbiosis-inducing systemic inflammatory pathways. As such, identical experimental
methods were conducted as was described within the infected zebrafish group except
ΔΔCt values were calculated in order to identify differential gene fold expression for high
fat diet treated zebrafish as compared to control diet fed zebrafish.

Figure 8. Gene expression of IL-1β (Red) and IL-6 (Green) is upregulated (n.s.) in
Candida infected zebrafish larvae. TNF-ɑ (Red) is depressed (n.s.) in Candida infected
zebrafish larvae. Pooled ΔΔCt of high fat diet qPCR replicate experiments Trial 1 and 2
were compiled due to high similarity between samples. Bar plots and error bars represent
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Mean and SD. Ct values correspond to initial qPCR Cycle threshold output values. ΔCt
values indicate the difference between target and non-target gene expression. ΔΔCt
values indicate the difference between single high fat diet treated larvae ΔCt values and
the average ΔCt value of control larvae. Thus, -ΔΔCt values represent the direction of
fold change in gene expression.

As seen in Figure 8 above, both IL-1β and IL-6 exhibit negative ΔΔCt values
when comparing high fat fed zebrafish larvae gene expression to that of control diet
zebrafish larvae. However, the differential expression observed in both TNF-ɑ and IL-1β
shown above is relatively insignificant, or close to zero, while IL-6 appears to be highly
upregulated in comparison. Most notably, IL-6 also showed the most profound negative
ΔΔCt value, and therefore the greatest increase in gene fold expression, in the proinflammatory positive control group, Candida infected zebrafish. Thus, qPCR analysis of
both the infected zebrafish larvae and the high fat diet treated zebrafish larvae could
provide grounds suggesting that both infection and Western Diet elicit an IL-6 mediated
pro-inflammatory response leading to perturbed sleep states. At the same time, however,
future research will need to assess the relatively low sample size in both experimental
groups in order to compensate for the natural variation of cytokine gene expression
between individual zebrafish larvae in order to better elucidate this potential signaling
mechanism.
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VIII. Correlation Between Pro-inflammatory Cytokine Gene Expression and Specific
Zebrafish Sleep Variables
The differentially expressed pro-inflammatory cytokine gene expression observed
between control and experimental groups treated with different means of inflammationinducing mechanisms holds promise for future work in elucidating the physiological
phenomena underlying the connection between diet and sleep quality, particularly in
regards to the role of IL-6 in modulating these events. As such, exploratory correlation
models were conducted to attempt to pinpoint an association between specific elevated
cytokine gene expression and distinct sleep variable metrics. The results of these
exploratory analyses for both Trial 1 and Trial 2 of the Candida infected experimental
group are described below. The high fat diet experimental group was not incorporated in
these analyses due to low sample size and absence of single fish sleep metrics in both
qPCR trials.
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Figure 9. Exploratory linear regression analyses of individual sleep variables and
TNF-ɑ (Blue), IL-1β (Red), and IL-6 (Green) ΔCt values for infected zebrafish
qPCR Trial 1. (A) Single fish Total Sleep Duration (minutes). (B) Single fish sleep %.
(C) Single fish number of sleep bouts. (D) Single fish mean sleep bout length (minutes).
(E) Single fish fragmentation index. All sleep variables are plotted against the single fish
ΔCt. Trend lines represent linear least squares regression lines.
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While the ΔΔCt typically provides information necessary for interpreting gene
fold expression, it eliminates the quantification of zebrafish at the single larvae level
given that it is calculated by subtracting the average ΔCt of the control group from the
single fish ΔCt of each experimental larvae. Thus, in order to assess a relationship
between each individual fish’s inflammatory cytokine expression profile and sleep
quality, ΔCt values were plotted as opposed to ΔΔCt values. In these plots, each point
represents a single fish with the y-axis indicating its ΔCt value for a given target gene and
the x-axis indicating its sleep quality described by the defined variable. As such these
plots allow for quantification of any potential relationship between pro-inflammatory
cytokine ΔCt values and sleep disruption of single zebrafish larvae. Least squares
regression lines were fitted to each cytokine, TNF-ɑ (Blue), IL-1β (Red), and IL-6
(Green), and the R2 value of each regression line was interpreted to quantify how well
each regression line fit the dataset. R2 values have a range from 0-1 with 1 being a perfect
fit to the linear descriptive equation. However, the only R2 value reporting over 50%
(0.5) was that which described the relationship between elevated IL-1β expression and
single fish Fragmentation Indexes (R2=0.6723). Thus, the exploratory analyses of the
infected zebrafish larvae Trial 1, as well as the sleep variables of each single fish being
plotted, indicate an association between increasing IL-1β expression and elevated sleep
fragmentation.
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Figure 10. Exploratory linear regression analyses of individual sleep variables and
TNF-ɑ (Blue), IL-1β (Red), and IL-6 (Green) ΔCt values for infected zebrafish
qPCR Trial 2. (A) Single fish total sleep duration (minutes). (B) Single fish Sleep %.
(C) Single fish number of sleep bouts. (D) Single fish mean sleep bout length (minutes).
(E) Single fish fragmentation index. All sleep variables are plotted against the single fish
ΔCt. Trend lines represent linear least squares regression lines.
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Identical plotting methods were conducted for infected zebrafish larvae qPCR
Trial 2. As seen in the scatterplots above(Figure 10) and numerically in Appendix H, the
ΔCt values of qPCR Trial 2 were much tighter than those of Trial 1. Thus, more
information could be determined from plotting the results of the qPCR experiment
against the single fish sleep variables discussed previously. Again, linear least squares
regression lines were calculated with any linear regression reporting an R2 value over 0.5
being deemed an acceptable ‘fit’. A trend for the correlation was observed between
inflammatory cytokine ΔCt values and individual sleep variables in infected zebrafish
larvae. For one, a correlation between increased TNF-ɑ expression (R2=0.8819) as well
as increased IL-6 expression (R2=0.8212) and an increase in the number of sleep bouts
was observed. Further, a correlation between increased TNF-ɑ expression (R2=0.9279)
and elevated mean sleep bout length was observed. Finally, a correlation between
increased IL-6 expression (R2=0.6567) and greater Fragmentation Indexes was observed.
As such, the results of

62

DISCUSSION
Clinical implications of sleep disturbances are becoming increasingly apparent
thereby increasing the demand for research aimed at elucidating the physiological
mechanisms which relate disease states and sleep disruption. Further, a more robust
understanding of how basic lifestyle factors, such as diet, influence sleep quality is a
critical component of such research. Preliminary results reported by Hayes suggested that
aging adults who consumed a diet higher in fat and free sugar exhibited poorer sleep
quality, particularly in regards to sleep duration-related metrics and sleep fragmentation.
In line with previous work which has found that Western diet induces gut-dysbiosis as
well as elevated pro-inflammatory cytokine expression it was subsequently hypothesized
that aging individuals who consumed a more severe Western diet experienced proinflammatory signaling known to contribute to sleep disruption[80,81]. To assess parts of
this hypothesized mechanism of causation, a reverse-translational protocol was optimized
to attempt to model this phenomenon in zebrafish. Zebrafish larvae (≤5 dpf) were
administered a high fat or control diet beginning at 3 dpf before being subjected to a 35
minute sleep analysis at 5 dpf. Another experimental group of zebrafish was not
controlled by diet but instead received direct infection of human fungal pathogen,
Candida, or a mock infection. Both were intended to mimic the hypothesized
inflammatory state induced by the aforementioned high fat diet. Following sleep analysis,
each larvae was used for single fish qPCR to measure pyrogenic cytokine gene
expression. The pro-inflammatory cytokines selected (i.e. TNF-ɑ, IL-1β, and IL-6) were
selected as they are also known to have somnogenic properties[23]. Thus, cytokine gene
expression was analyzed separately from sleep quality to attempt to identify first if sleep
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disruption was observed and subsequently if any perturbed sleep quality was correlated
with elevated pro-inflammatory gene expression.

Figure 11. Schematic representation of how each component of the reversetranslational study aimed to address a unique piece of the multi-part hypothesis. (A)
The 35 min zebrafish sleep analysis was designed to first identify if Candida infected or
high fat diet treated zebrafish larvae exhibited sleep disruption when compared to their
respective controls (Figures 3-6). (B) The post-sleep analysis qPCR method was designed
to assess if Candida infected or high fat diet treated zebrafish larvae exhibited greater
pro-inflammatory cytokine gene expression (Figures 7-8). (C) The sleep vs. qPCR
scatterplots were designed to assess if differential sleep quality observed in either
Candida infected or high fat diet treated zebrafish larvae was associated with proinflammatory cytokine gene expression (Figures 9-10). Particularly in regards to the diet64

controlled group, this experimental design was meant to assess each particular piece of
the multi-part hypothesis that Western diet induced gut-dysbiosis was the trigger for proinflammatory cytokine mediated sleep disruption.

Our preliminary results suggest for the first time that infected zebrafish larvae and
high fat diet treated zebrafish larvae both exhibit a greater number of sleep bouts than
their respective controls as well as a possible trend (not statistically significant) for
elevated IL-6 gene expression. Though future studies are necessary to compensate for the
small sample size of the dietary group in the present study, these results suggest that a
pro-inflammatory signaling pathway may be induced by a high fat diet in zebrafish and
subsequently altering sleep disruption.

Zebrafish Sleep Analysis
In 80% of replicate sleep analysis trials, Candida infected larvae exhibited greater
total sleep duration, sleep %, and mean sleep bout length than control larvae and, in 60%
of replicate sleep analysis trials, Candida infected zebrafish larvae exhibited a greater
number of sleep bouts than control larvae. Similarly, though no statistically significant
correlations or trends were noted, high fat diet treated zebrafish larvae exhibited a greater
number of sleep bouts and fragmentation index than control diet larvae. The high
variability of sleep quality between control and experimentally-treated zebrafish in repeat
experimental trials highlights the importance for further optimization of velocity-based
sleep studies. In particular, replicating the experimental methods published by Sorribes et
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al (2013) required several non-data producing trials due to pitfalls that were not described
in previous literature[3]. Namely, the use of 1-phenyl 2-thiourea (PTU) to inhibit the
pigmentation of zebrafish larvae, a common practice in zebrafish husbandry to simplify
injection and imaging procedures, disrupted the ability of the Noldus Vision Device from
differentiating the nearly translucent larvae from the clear background water. Thus, the
protocol was modified to not include PTU treatment with zebrafish larvae up to 5 dpf.
Even once pre-sleep analysis husbandry was designed in a manner such that larvae could
properly be distinguished from background signal of flow-by water, high variability was
observed between experimental trials. In part, this could be due to the fact that the young
zebrafish larvae were not fully entrained to the 10-hour light/14-hour dark cycles and,
thus, their circadian rhythm and behavioral sleep state may have been at different points
during the designated sleep analysis period. However, given that previous research
reports that zebrafish sleep-wake transitions decrease with age, larvae were determined to
be the most appropriate model in assessing fragmentation-related variables, were more
conducive to a time-restricted study, and offer a variety of physiological advantages to
older zebrafish larvae (e.g. natural translucent appearance simplifies infection protocols).
Future studies could also assess zebrafish sleep analysis at different time points during
the day (e.g. ‘morning’ for early in light cycle, ‘afternoon’ for midway point of light
cycle, etc.) to monitor light-dark entrainment or even, with more optimization, to assess
‘daytime sleepiness’. While large variability may have rendered the pooled zebrafish
sleep variables (Appendix C) non-statistically significant, assessing trends within
biological repeat trials appeared to produce several noteworthy trends. Namely, that
Candida infected zebrafish larvae tend to exhibit greater total sleep Duration, Sleep %,
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number of sleep bouts, and mean sleep bout length when compared to non-infected larvae
administered a placebo mock injection. This suggests that Candida infection induces
sleep disruption in zebrafish larvae. Furthermore, though not observed to be statistically
significant, high fat fed zebrafish larvae also exhibited a greater number of sleep Bouts as
well as a larger fragmentation index. This suggests that a high fat diet is associated with a
trend for sleep disruption in zebrafish larvae. The uneven control and experimental group
size and lack of biological replicates likely contributed to the lack of statistically
significant findings of the diet-controlled zebrafish group. In summary, despite a lack of
statistical evidence for the high fat treated zebrafish group, these findings are not
inconsistent with the hypothesis that a high fat diet or direct infection would induce sleep
disruption in zebrafish larvae. In order to elucidate if these associative findings were
mediated by pro-inflammatory cytokine signaling, the gene expression of TNF-ɑ, IL-1β,
and IL-6 were analyzed in control and treated zebrafish and then plotted against each
sleep variable.

Zebrafish Inflammatory Cytokine qPCR Analysis
To investigate the our hypothesis that inflammatory signaling would disrupt sleep
in zebrafish larvae, each zebrafish larvae measured for sleep analysis was subjected to
single fish qPCR aimed at quantifying gene expression of the extensively studied
pyrogenic and somnogenic cytokines TNF-ɑ, IL-1β, and IL-6. The initial qPCR Trial 1 of
the infected zebrafish group showed wide variability between biological replicates and
errors in control gene quantification (Appendix F). This result was likely due to crude
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experimental technique as subsequent repeat trials for both infected and diet-controlled
were considerably more consistent and properly controlled (Appendix F, G). Using a
Mann-Whitney test to compare the ΔΔCt of Candida infected and control zebrafish
larvae, no statistically significant associations nor trends were reported. The depressed ΔΔCt of IL-1β in Trials 1 and 2 of the infected larvae contradicted the anticipated result
that IL-1β would be upregulated in the presence of fungal infection (Fradin et al 2007).
This result, however, could be due to natural variability between zebrafish larvae and not
necessarily an actual downregulation of IL-1β in infected zebrafish. What was observed
in both Trials 1 and 2, as well as the pooled data set, was a non-significant increase in
TNF-ɑ and particularly IL-6 expression as gathered by the -ΔΔCt values(Figure 7). This
suggests that infected zebrafish larvae are associated with both sleep disruption and a
trend for elevated gene expression of inflammatory cytokines TNF-ɑ and IL-6.
In regards to the diet-controlled zebrafish group, given the small sample size and
absence of statistically significant variation between control and experimental groups, the
minimal change in both TNF-ɑ and IL-1β gene expression did not come as a surprise.
However, similar to that of the infected zebrafish group, there was an increase in IL-6 ΔΔCt as compared to control zebrafish larvae. In future studies, this experiment should
attempt to be replicated to further support this preliminary observation. However, the
consistent elevated gene expression of IL-6 in both Candida infected and high fat diet
treated zebrafish larvae may support a mutual inflammatory pathway inducted by two
distinct external factors.
Several statistically significant associations were noted, consistent with the
hypothesis that Candida infection would induce sleep disruption in zebrafish. Similarly, a
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non significant trend for an association correlating Candida infection and high fat diet
treatment to elevated IL-6 gene expression was observed. However, these findings were
not consistent between entire control or treated groups due to wide variability between
both sleep variables and gene expression in repeat experimental trials. However, to
determine if any relationship between elevated inflammatory cytokine gene expression
and sleep disruption could be observed at the single fish level, each single fish ΔCt value
was plotted against each single fish sleep variable (Figure 9 and 10). As indicated by
more statistically relevant least squares linear regression R2 values being observed in
infected qPCR Trial 2, identifying any correlation between inflammatory cytokine gene
expression and sleep variables requires tight qPCR biological replicate production. While
several interesting trends were observed which suggested an association between proinflammatory cytokine elevated gene expression and differential sleep quality, the
relatively small sample size of each single fish qPCR (ranging from 2-5 larvae) may have
skewed these results. In addition to this, like humans, each zebrafish larvae is not 100%
genetically identical so variation in sleep quality, response to diet, or response to
infection may also be due to natural variation between fish.
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FUTURE DIRECTIONS
Future work should aim both to further optimize the methods of this study as well
as to attempt to elucidate more of the molecular interactions which may underlie the
correlations observed between inflammatory cytokine gene expression and sleep
disruption. In regards to experimental method improvements, this study should be
replicated with non-velocity based zebrafish sleep analyses so that sleep variables
involved in immobility, which are commonplace metrics in human sleep analysis, can be
analyzed as well. That is, while metrics such as mean number of immobile phases may be
assessed in humans, given that sleep was defined in zebrafish as periods of immobility, it
is impossible to distinguish general sleep-like behavior from immobile phases within
sleep. In addition to this, a checkpoint step between high fat feeding and inflammatory
cytokine gene expression could be done, such as 16s rRNA analysis (e.g.Arias-Jayo,
2018) in order to confirm diet-induced gut dysbiosis prior to assessing differential
inflammatory signaling. Furthermore, assessing the results of identical experimental
methods on zebrafish at different stages during development, namely adult zebrafish,
could prove interesting given that longer exposure to a high fat diet could have a greater
impact on the state of typical gut microflora and subsequent immune response.
In regards to further research involving the molecular mechanisms underlying the
relationship between diet and sleep quality in zebrafish, the most promising result of the
provided study was the mutual elevation of IL-6 gene expression observed in both high
fat diet treated zebrafish, who were hypothesized to be experiencing gut-dysbiosis
induced inflammation, as well as Candida infected zebrafish, who were meant to serve as
a positive control for systemic inflammation. As such, further work should first and
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foremost attempt to replicate these findings in larger sample sizes and then attempt to
elucidate if elevated IL-6 production is specific to any tissue(s) in infected and high fat
diet treated zebrafish. Future work could even attempt to create mutant fluorescently
tagged IL-6 zebrafish optimized such that, when activated, the upstream IL-6 promoter
would induce gene expression of a fluorescent IL-6 protein, such that the location and
fluorescence quantification of IL-6 expression in infected and diet-controlled zebrafish
could be assessed via microscopy techniques. Namely, it would be interesting to observe
if IL-6 expression, which would first elevate at the site of infection (i.e. hindbrain) or
within the gut, could be observed to travel throughout the CNS in the case of hindbrain
infection or travel to the CNS in the case of the gut dysbiosis mechanism.
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APPENDIX B
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APPENDIX C

Zebrafish Sleep Variables for Infected Sleep Analysis Trials 1-6
Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 1 Groups
Sleep Variable

Mock PBS Injection
(n=11)
30.72 ± 1.62
29.27 ± 10.67

Active Candida
Infection (n=9)
31.79 ± 3.73
15.22 ± 8.27

p-value

Total Sleep Duration
0.01831
Number of Sleep
0.002322
Bouts
Mean Sleep Bout
1.19 ± 0.49
2.97 ± 2.05
0.005955
Length
Fragmentation Index 0.972 ± 0.419
0.519 ± 0.362
0.009936
Sleep %
87.86 ± 4.57
90.84 ± 10.66
0.01831
Total Wake Duration 4.282 ± 1.625
3.207 ± 1.358
0.01831
Number of Wake
30 ± 10.67
16.22 ± 7.432
0.002322
Bouts
Mean Wake Bout
0.14 ± 0.03
0.164 ± 0.026
0.44038
Length
Wake %
12.14 ± 4.57
9.159 ± 3.876
0.01831
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 2 Groups
Sleep Variable

Mock PBS Injection
(n=10)
13.10 ± 5.08
77.00 ± 10.63

Active Candida
Infection (n=12)
17.77 ± 3.61
82.00 ± 16.17

p-value

Total Sleep Duration
0.012241
Number of Sleep
0.197143
Bouts
Mean Sleep Bout
0.17 ± 0.08
0.22 ± 0.06
0.070101
Length
Fragmentation Index 6.85 ± 2.77
4.774 ± 1.367
0.021788
Sleep %
37.44 ± 14.51
50.76 ± 10.31
0.047857
Total Wake Duration 21.90 ± 5.08
17.235 ± 2.289
0.012241
Number of Wake
78 ± 10.63
83 ± 16.17
0.197143
Bouts
Mean Wake Bout
0.284 ± 0.071
0.192 ± 0.101
0.00466
Length
Wake %
43.43 ± 14.51
52.02 ± 13.54
0.047857
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 3 Groups
Sleep Variable
Total Sleep Duration
Number of Sleep
Bouts
Mean Sleep Bout
Length
Fragmentation Index
Sleep %
Total Wake Duration

Mock PBS Injection
(n=0)
N/A
N/A

Active Candida
Infection (n=5)
25.58 ± 5.23
49.40 ± 16.74

p-value

N/A

0.58 ± 0.27

N/A

N/A
N/A
N/A

2.048 ± 0.089
73.08 ± 14.95
9.42 ± 5.23

N/A
N/A
N/A

N/A
N/A

Number of Wake
N/A
50 ± 16.74
N/A
Bouts
Mean Wake Bout
N/A
0.188 ± 0.104
N/A
Length
Wake %
N/A
26.918 ± 14.95
N/A
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 4 Groups
Sleep Variable

Mock PBS Injection
(n=11)
19.75 ± 3.34
70.82 ± 10.68

Active Candida
Infection (n=9)
22.43 ± 6.24
67.33 ± 28.50

p-value

Total Sleep Duration
0.116424
Number of Sleep
0.35553
Bouts
Mean Sleep Bout
0.28 ± 0.06
0.58 ± 0.72
0.46812
Length
Fragmentation Index 3.592 ± 0.747
3.498 ± 2.032
0.443771
Sleep %
56.42 ± 9.53
66.65 ± 18.94
0.111016
Total Wake Duration 15.256 ± 3.35
12.566 ± 6.242
0.116424
Number of Wake
71.818 ± 10.675
68.33 ± 28.504
0.35553
Bouts
Mean Wake Bout
0.219 ± 0.074
0.175 ± 0.029
0.07493
Length
Wake %
43.58 ± 9.53
35.35 ± 18.94
0.111016
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 5 Groups
Sleep Variable

Mock PBS Injection
(n=10)
26.26 ± 3.19
51.00 ± 17.55

Active Candida
Infection (n=12)
16.12 ± 6.84
76.92 ± 24.68

p-value

Total Sleep Duration
0.000173
Number of Sleep
0.00135
Bouts
Mean Sleep Bout
0.64 ± 0.44
0.51 ± 1.15
0.00056
Length
Fragmentation Index 2.023 ± 0.860
5.972 ± 3.042
0.000385
Sleep %
75.53 ± 9.10
46.07 ± 19.53
0.000145
Total Wake Duration 8.738 ± 3.187
18 ± 6.843
0.000173
Number of Wake
52 ± 17.55
77.917 ±24.678
0.00135
Bouts
Mean Wake Bout
0.168 ± 0.023
0.240 ± 0.044
0.00027
Length
Wake %
24.575 ± 9.097
53.928 ± 19.525
0.000145
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.

88

Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 6 Groups
Sleep Variable

Mock PBS Injection
(n=12)
15.804 ± 6.886
74.833 ± 22.894

Active Candida
Infection (n=12)
15.904 ± 6.913
76.083 ± 23.907

p-value

Total Sleep Duration
0.42074
Number of Sleep
0.38591
Bouts
Mean Sleep Bout
0.512 ± 1.145
0.562 ± 1.322
0.48803
Length
Fragmentation Index 5.818 ± 2.804
5.879 ± 2.867
0.479399
Sleep %
45.15 ± 19.67
45.44 ± 19.75
0.42074
Total Wake Duration 19.20 ± 6.886
19.096 ± 6.913
0.42074
Number of Wake
75.833 ± 22.894
77.083 ± 23.907
0.15386
Bouts
Mean Wake Bout
0.249 ± 0.043
0.245 ± 0.043
0.405876
Length
Wake %
54.845 ± 19.674
54.560 ± 19.753
0.42074
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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APPENDIX D

Zebrafish Sleep Variables for High Fat Diet Sleep Analysis

Sleep Variables for Control Diet vs. High Fat Diet Trial 1 Groups
Sleep Variable
Control Diet (n=12) High Fat Diet (n=4) p-value
Total Sleep Duration 15.989 ± 6.866
13.954 ± 3.606
0.292666
Number of Sleep
76.583 ± 23.57
84 ± 11.165
0.715805
Bouts
Mean Sleep Bout
0.473 ± 1.014
0.172 ± 0.067
0.683516
Length
Fragmentation Index 5.869 ± 2.858
6.446 ± 2.294
0.683516
Sleep %
45.68 ± 19.62
39.87 ± 10.3
0.952747
Total Wake Duration 19.011 ± 6.866
21.046 ± 3.606
0.292666
Number of Wake
77.583 ± 23.57
85 ± 11.165
0.715805
Bouts
Mean Wake Bout
0.240 ± 0.045
0.247 ± 0.019
0.394092
Length
Wake %
54.31 ±19.62
60.13 ± 10.3
0.292668
Note. x ± y represents the mean ± standard deviation of the mean (SDM), (n) = sample
size.
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APPENDIX E

List of Primers for qPCR
GAPDH:
Forward: 5’- TGG GCC CAT GAA AGG AAT -3’
Reverse: 5’- ACC AGC GTC AAA GAT GGA TG -3’

TNF-ɑ:
Forward: 5’- CGC ATT TCA CAA GGC AAT TT -3’
Reverse: 5’-CTG GTC CTG GTC ATC TCT CC -3’

IL-1𝛃:
Forward: 5’- GTC ACA CTG AGA GCC GGA AG -3’
Reverse: 5’- TGG AGA TTC CCA AAC ACA CA -3’

IL-6
Forward: 5’- CTG GTA GCC GAG AGG GGA A-3’
Reverse: 5’- CCC ATA CTG CTG AAC ACG GG -3’
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APPENDIX F

Single Fish Ct, ΔCt, ΔΔCt, and Fold Change qPCR Values for Infected qPCR Trials 1
and 2
Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for
Mock PBS Injection vs. Active Candida Infection Trial 1 Group.
Gene of
Interest

Single
Fish
ID

Single Fish
Ct Values
(duplicate)

GAPDH
(Control)

IA1

/, 19.13

IB2
IC4
MA3
MC2
MC3
IA1
IB2
IC4
MA3
MC2
MC3
IA1
IB2
IC4
MA3
MC2
MC3
IA1
IB2
IC4
MA3
MC2
MC3

21.5, 20.95
27.66, 21.01*
20.51, 17.35
17.14, 17.02
18.82, 18.9
/, /
34.57, 31.9
31.37, 31.66
31.06, 31.34
32.18, 31.4
32.73, 34.25
26.81, /
/, 24.25
23.89, 23.99
23.42, 23.75
24.57, 25.16
21.75, 22.05
26.23, 27.22
24.54, 25.14
29.51, 28.51
22.57, 36.3*
34.12, 33.21
26.22, 27.18

TNF-ɑ

IL-1β

IL-6

Single
Fish
Average
Ct
Values
19.14

∆Ct
Value

21.225

N/A
N/A
N/A
N/A
N/A

18.93
17.06
18.86

∆∆Ct
Value

Fold
Change

N/A

33.235
31.515**
31.2
31.79
33.49
26.81
24.25
23.94**
23.585
24.865
21.9
28.725
24.84
58.02**

12.01

-1.867

3.647

12.27
14.73
14.63
7.37
3.025

2.203
-2.142

0.217
4.413

4.655
7.805
3.04
7.585
3.615

-4.638
-8.608

24.890
390.046

33.665
26.7

16.605
7.84
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Note. Single Fish IDs beginning with ‘I’ indicate Active Candida Infection, Single Fish
IDs beginning with ‘M’ indicate Mock PBS Injection, ‘/’ indicates that no readout was
provided, ‘*’ indicates that significant variation occurred between duplicate Ct Values
such that Average Ct Values were not determined, ‘**’ indicates that experimental error
occurred in the GAPDH Control.
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Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for
Mock PBS Injection vs. Active Candida Infection Trial 2 Group.
Gene of
Interest

Single
Fish
ID

Single Fish
Ct Values
(duplicate)

GAPDH
(Control)

IA1

21.87, 21.87

Single
Fish
Average
Ct
Values
21.87

∆Ct
Value

∆∆Ct
Value

Fold
Change

N/A

IB1
23.19, 23.74
23.46
N/A
MA2
21.47, 21.57
21.52
N/A
MB1
26.27, 26.38
21.87
N/A
TNF-ɑ
IA1
37.13, 38.29
37.71
15.84
-0.58
1.495
IB1
38.89, 37.52
38.2
14.74
-1.68
3.204
MA2
/, 37.94
37.94
16.42
MB1
/, /
N/A
N/A
IL-1β
IA1
29, 28.75
28.88
7.01
2.64
0.160
IB1
27.74, 27.47
27.6
4.14
-0.23
1.172
MA2
27.61, 26.97
27.29
5.77
MB1
28.79, 29.82
29.3
2.97
IL-6
IA1
35.28, 34.34
34.81
12.94
0.005
0.997
IB1
33.97, 33.43
33.7
10.24
-2.695
6.476
MA2
35.87, 35.31
35.59
14.07
MB1
39.09, 37.17
38.13
11.8
Note. Single Fish IDs beginning with ‘I’ indicate Active Candida Infection, Single Fish
IDs beginning with ‘M’ indicate Mock PBS Injection, ‘/’ indicates that no readout was
provided, ‘*’ indicates that significant variation occurred between duplicate Ct Values
such that Average Ct Values were not determined, ‘**’ indicates that experimental error
occurred in the GAPDH Control.
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APPENDIX G

Single Fish Ct, ΔCt, ΔΔCt, and Fold Change qPCR Values for High Fat Diet qPCR Trials
1 and 2
Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for
Control Diet vs. High Fat Diet Trial 1 Group.
Gene of
Interest

Single
Fish
ID

Single Fish
Ct Values
(duplicate)

GAPDH
(Control)

CB1
CB2
CB3
CB4
HB2
HB3
HB4
CB1
CB2
CB3
CB4
HB2
HB3
HB4
CB1
CB2
CB3
CB4
HB2
HB3
HB4
CB1
CB2
CB3
CB4

TNF-ɑ

IL-1β

IL-6

∆Ct
Value

17.69, 17.35

Single
Fish
Average
Ct
Values
17.52

16.59, 16.9
20.77, 20.63
23.2, 23.28
22.78, 22.8
17.18, 17.49
16.67, 16.68
32.21, 30.37
30.82, 30.96
33.88, 34.14
35.08, 35.51
34.5, 34.75
31.75, 31.65
31.39, 30.22
23.17, 22.78
22.02, 21.81
22.97, 22.63
24.04, 24.09
22.9, 22.85
24, 24.28
23.68, 23.4
34.29, 31.63
29.51, 26.6
26.79, 26.6
27.97, 28.29

16.745
20.7
23.2
22.78
17.335
16.675
31.29
30.89
34.01
35.295
34.625
31.7
30.805
22.975
21.915
22.8
24.065
22.875
24.14
23.54
32.96
28.055
26.695
28.13

N/A
N/A
N/A
N/A
N/A
N/A
13.77
14.145
13.31
12.095
11.845
14.365
14.13
5.455
5.17
2.1
0.865
0.095
6.805
6.865
15.44
11.31
5.995
4.93
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∆∆Ct
Value

Fold
Change

-1.485
1.035
0.8

2.799
0.488
0.574

-3.303
3.408
3.468

9.866
0.094
0.090

N/A

Table continued
HB2

27.23, 27.78

27.505

4.725

-4.693

25.880

HB3
24.11, 25.84
24.975
7.64
-1.779
3.431
HB4
25.99, 23.97
24.98
8.305
-1.114
2.164
Note. Single Fish IDs beginning with ‘C’ indicate Control Diet, Single Fish IDs
beginning with ‘H’ indicate High Fat Diet, ‘/’ indicates that no readout was provided, ‘*’
indicates that significant variation occurred between duplicate Ct Values such that
Average Ct Values were not determined, ‘**’ indicates that experimental error occurred
in the GAPDH Control.
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Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for
Control Diet vs. High Fat Diet Trial 2 Group.
Gene of
Interest

Single
Fish
ID

Single Fish
Ct Values
(duplicate)

GAPDH
(Control)

CB1

22.93, 21.14

Single
Fish
Average
Ct
Values
22.035

∆Ct
Value

∆∆Ct
Value

Fold
Change

N/A

CB2
19.75, 20.09
19.92
N/A
CB3
20.01, 19.4
19.705
N/A
CB4
19.3, 18.78
19.3
N/A
HB4
17.65, 17.3
17.65
N/A
HC1
17.44, 17.4
17.42
N/A
HC2
16.85,17.04
16.945
N/A
TNF-ɑ
CB1
33.03, 33.25
33.14
11.105
CB2
33.06, 32.91
32.985
13.605
CB3
34.72, 37.36
36.04
16.335
CB4
32.37, 32.1
32.235
12.945
HB4
30.81, 30.73
30.77
13.12
-0.24
1.181
HC1
30.99, 31.96
31.475
14.055
0.695
0.618
HC2
30.27, 30.76
30.515
13.57
0.21
0.865
IL-1β
CB1
27.58, 30.23
28.905
6.87
CB2
32.08, 27.56
29.82
9.9
CB3
30.17, 28.05
29.11
9.405
CB4
27.05, 26.29
26.67
7.37
HB4
24.04, 24.01
24.025
6.375
-2.011
4.031
HC1
24.35, 24.47
24.41
6.99
-1.400
2.632
HC2
23.56, 23.35
23.455
6.51
-1.876
3.671
IL-6
CB1
32.72, 34.1
33.41
11.375
CB2
31.33, 29.55
30.44
10.52
CB3
30.84, 27.75
29.295
9.59
CB4
24.86, 24.33
24.595
5.295
HB4
24.03, 23.2
23.615
5.965
-3.23
9.383
HC1
23.11, 24.2
23.655
6.235
-2.96
7.781
HC2
24.11, 22.6
23.55
6.41
-2.785
6.892
Note. Single Fish IDs beginning with ‘C’ indicate Control Diet, Single Fish IDs
beginning with ‘H’ indicate High Fat Diet, ‘/’ indicates that no readout was provided, ‘*’
indicates that significant variation occurred between duplicate Ct Values such that
Average Ct Values were not determined, ‘**’ indicates that experimental error occurred
in the GAPDH Control.
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APPENDIX H

Whole-study Zebrafish Sleep Variable Summary

Single fish sleep variables for infected analysis group (Trials 1-6) and diet analysis
group (Trial 1).
Mean
Mean
sleep Fragme
Total #
Total
# wake
Fish sleep Sleep bout ntation Sleep wake wake bout Wake
ID duration bouts length index %
duration bouts length %
Contro
l
A1 32.920

15.000 131.67 0.456

94.05
0
2.080

16.00
0
0.130

5.950

22.000 88.320 0.679

92.52
0
2.620

23.00
0
0.114

7.480

27.000 69.590 0.862

89.48
0
3.680

28.00
0
0.131

10.520

35.000 50.430 1.190

85.05
0
5.580

36.00
0
0.155

14.950

B1 26.900

53.000 30.450 1.970

76.86
0
8.100

54.00
0
0.150

23.140

B2 /

/

/

/

/

Trial 1 A2 32.380
A3 31.320
A4 29.420

B3 30.950
B4 30.980
C1 31.200
C2 31.630

/

/

/

/

32.000 58.030 1.034

88.43
0
4.050

33.00
0
0.123

11.570

29.000 64.100 0.936

88.52
0
4.020

30.00
0
0.134

11.480

17.000 110.12 0.545

89.14
0
3.800

18.00
0
0.211

10.860

24.000 75.080 0.759

90.38
0
3.370

25.00
0
0.135

9.620
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39.000 45.820 1.309

85.10
0
5.220

40.00
0
0.131

14.900

29.000 62.930 0.953

86.90
0
4.580

30.00
0
0.153

13.100

Infecte
d
A1 22.350

29.000 46.240 1.298

63.86
0
12.650

30.00
0
0.422

36.140

Trial 1 A2 33.180

12.000 165.92 0.398

94.81
0
1.820

13.00
0
0.140

5.190

A3 /

/

/

/

/

/

/

/

/

A4 /

/

/

/

/

/

/

/

/

C3 29.780

C4 30.420

5.000 411.60 0.146

98.00
0
0.700

6.000 0.117

2.000

11.000 184.00 0.326

96.38
0
1.270

12.00
0
0.106

3.620

6.000 342.83 0.175

97.95
0
0.720

7.000 0.103

2.050

21.000 89.810 0.668

89.81
0
3.570

22.00
0
0.162

10.190

C1 30.980

25.000 74.360 0.807

88.52
0
4.020

26.00
0
0.155

11.480

C2 /

/

/

/

/

B1 34.300
B2 33.730
B3 34.280
B4 31.430

/

/

/

/

12.000 167.58 0.358

95.76
0
1.480

13.00
0
0.114

4.240

16.000 121.38 0.494

92.48
0
2.630

17.00
0
0.155

7.520

76.000 6.530 9.190

23.62
0

Trial 2 A2 12.420

79.000 9.430 6.480

35.69
0
22.580

80.00
0
0.282

64.310

A3 11.080

92.000 7.230 8.300

31.65 23.920

93.00 0.257

68.350

C3 33.520

C4 32.370
Contro
l
A1

8.270

99

77.00
26.730
0 0.347

76.380

A4 7.570
B1 13.750
B2 20.630
B3 5.830
B4 12.250
C1 18.270
C2 18.270
C3 9.070

C4 19.800
infecte
d
A1

0

0

79.000 5.750 10.440

21.62
0
27.430

80.00
0
0.343

78.380

93.000 8.870 6.760

39.27
0
21.250

94.00
0
0.226

60.730

59.000 20.980 2.860

58.93
0
14.370

60.00
0
0.240

41.070

66.000 5.300 11.320

16.65
0
29.170

67.00
0
0.435

83.350

81.000 9.070 6.610

35.00
0
22.750

82.00
0
0.277

65.000

85.000 12.900 4.650

52.20
0
16.730

86.00
0
0.195

47.800

62.000 17.680 3.390

52.20
0
16.730

63.00
0
0.266

47.800

75.000 7.260 8.270

25.91
0
25.930

76.00
0
0.341

74.090

77.000 15.430 3.890

56.57
0
15.200

78.00
0
0.195

43.430

44.00
21.850
0 0.497

62.430

13.150 43.000 18.350 3.270

37.57
0

85.000 8.240 7.280

33.34
0
23.330

86.00
0
0.271

66.660

A3 /

/

/

/

/

/

/

/

/

A4 /

/

/

/

/

/

/

/

/

Trial 2 A2 11.670

B1 15.970
B2 21.550
B3 20.970

99.000 9.680 6.200

45.63
0
19.030

100.0
00
0.190

54.370

75.000 17.240 3.480

61.57
0
13.450

76.00
0
0.177

38.430

84.000 14.980 4.010

59.91
0
14.030

85.00
0
0.165

40.090

100

91.000 10.730 5.590

46.51
0
18.720

92.00
0
0.203

53.490

78.000 15.130 3.970

56.20
0
15.330

79.00
0
0.194

43.800

77.000 17.740 3.380

65.06
0
12.230

78.00
0
0.157

34.940

100.00 10.720 5.600

51.06
0
17.130

101.0
00
0.170

48.940

88.000 12.100 4.960

23.00
0
17.250

89.00
0
0.194

77.000

/

/

/

/

/

/

/

/

Trial 3 A2 /

/

/

/

/

/

/

/

/

A3 /

/

/

/

/

/

/

/

/

A4 /

/

/

/

/

/

/

/

/

B1 /

/

/

/

/

/

/

/

/

B2 /

/

/

/

/

/

/

/

/

B3 /

/

/

/

/

/

/

/

/

B4 /

/

/

/

/

/

/

/

/

C1 /

/

/

/

/

/

/

/

/

C2 /

/

/

/

/

/

/

/

/

C3 /

/

/

/

/

/

/

/

/

C4 /

/

/

/

/

/

/

/

/

/

/

/

/

/

/

/

/

Trial 3 A2 /

/

/

/

/

/

/

/

/

A3 /

/

/

/

/

/

/

/

/

B4 16.280
C1 19.670
C2 22.770
C3 17.870

C4 17.750
Contro
l
A1

Infecte
d
A1

/

/
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A4 /

/

B1 22.800
B2 25.970

73
60

/

/

/

18.740 3.200

65.17
0

/

/

/

/

74.00
0 0.165

34.830

25.970 2.310

74.19
0
9.030

61.00
0
0.148

25.810

45.00
0
0.373

47.950

12.200

B3 18.220

44

24.800 2.430

52.05
0
16.780

B4 /

/

/

/

/

/

/

/

/

C1 /

/

/

/

/

/

/

/

/

C2 30.620

33

55.670 1.080

87.48
0
4.380

C3 /

/

/

/

C4 30.280
Contro
l
A1

37

/

49.100 1.220

21.130 74.000 17.140 3.502

/

86.52
0
4.720
60.38
0

34.00
0
0.129

12.520

/

/

/

38.00
0
0.124

13.480

75.00
13.870
0 0.185

39.620

Trial 4 A2 19.280

83.000 13.940 3.304

55.10
0
15.720

A3 18.530

83.000 13.400 4.478

52.95
0
16.470

84.00
0
0.196

47.050

57.000 12.020 4.991

32.62
0
23.580

58.00
0
0.407

67.380

83.000 13.700 4.380

54.14
0
16.050

84.00
0
0.191

45.860

68.000 20.440 2.935

66.19
0
11.830

69.00
0
0.171

33.810

53.000 20.680 2.901

52.19
0
16.730

54.00
0
0.310

47.810

79.000 15.620 3.841

58.76
0
14.440

80.00
0
0.181

41.240

A4 11.420
B1 18.950
B2 23.170
B3 18.270
B4 20.560
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84.00
0
0.187

44.900

71.000 17.520 3.492

59.24
0
14.270

72.00
0
0.198

40.760

C2 20.830

62.000 20.160 2.976

59.52
0
14.170

63.00
0
0.225

40.480

C3 /

/

/

/

/

C1 20.730

/

/

/

/

69.48
0
10.680

67.00
0
0.159

30.520

99.43
0

15.00
0 0.130

0.570

90.000 11.430 5.248

49.00
0
17.850

91.00
0
0.196

51.000

A3 /

/

/

/

/

/

/

/

/

A4 /

/

/

/

/

/

/

/

/

C4 24.320
infecte
d
A1

66.000 22.110 2.714

33.050 14.000 141.60 0.424

Trial 4 A2 17.150

1.950

75.000 19.210 3.123

68.62
0
10.980

76.00
0
0.144

31.380

B2 22.200

68.000 19.590 3.063

63.43
0
12.800

69.00
0
0.186

36.570

B3 /

/

/

/

/

B1 24.020

B4 30.520
C1 19.350
C2 14.420
C3 17.230

C4 23.970
Contro
l
A1

/

/

/

/

29.000 63.140 0.950

87.19
0
4.480

30.00
0
0.149

12.810

87.000 13.340 4.496

55.29
0
15.650

88.00
0
0.178

44.710

93.000 9.300 6.451

41.19
0
20.580

94.00
0
0.219

58.810

90.000 11.490 5.222

49.24
0
17.770

91.00
0
0.195

50.760

60.000 23.970 2.503

68.48
0
11.030

61.00
0
0.181

31.520

74.19
0

60.00
0 0.151

25.810

25.970 59.000 26.410 2.272
103

9.030

25.000 73.760 0.813

87.81
0
4.270

26.00
0
0.164

12.190

46.000 34.930 1.717

76.52
0
8.220

47.00
0
0.175

23.480

45.000 36.890 1.627

79.05
0
7.330

46.00
0
0.159

20.950

58.000 26.910 2.229

74.33
0
8.980

59.00
0
0.152

25.670

67.000 21.520 2.788

68.67
0
10.970

68.00
0
0.161

31.330

B3 31.600

19.000 99.790 0.526

90.29
0
3.400

20.00
0
0.170

9.710

B4 /

/

/

/

/

Trial 5 A2 30.730
A3 26.780
A4 27.670
B1 26.020
B2 24.030

/

/

/

C1 21.230

59.000 21.590 2.779

60.67
0
13.770

C2 /

/

/

C3 23.170

C4 25.420
infecte
d
A1

/

/

/

/

60.00
0
0.230

39.330

/

/

/

74.000 18.780 3.194

66.19
0
11.830

75.00
0
0.158

33.810

58.000 26.290 2.282

77.62
0
9.580

59.00
0
0.162

22.380

73.00
15.830
0 0.217

45.240

19.170 72.000 15.970 3.756

54.76
0

Trial 5 A2 14.500

70.000 12.430 4.828

41.43
0
20.500

A3 10.670

106.00
0
6.030 9.938

30.48
0
24.330

107.0
00
0.227

69.520

87.000 8.170 8.817

33.86
0
23.150

88.00
0
0.263

66.140

B1 16.520

94.000 10.540 5.691

47.19
0
18.480

95.00
0
0.195

52.810

B2 16.830

89.000 11.350 5.287

48.10 18.170

90.00 0.202

51.900

A4 11.850

104

71.00
0
0.289

58.570

B3 10.380
B4 20.700
C1 20.650
C2 8.670
C3 33.170

C4 10.300
Contro
l
A1

0

0

87.000 7.160 8.379

29.67
0
24.620

88.00
0
0.280

70.330

68.000 18.270 3.285

59.14
0
14.300

69.00
0
0.207

40.860

70.000 17.700 3.390

59.00
0
14.350

71.00
0
0.202

41.000

79.000 6.580 9.115

24.76
0
26.330

80.00
0
0.329

75.240

8.000 248.7 0.241

94.76
0
1.830

9.000 0.203

5.240

93.000 6.710 8.942

29.71
0
24.700

94.00
0
0.263

70.290

72.00
15.900
0 0.221

45.429

19.100 71.000 0.269 3.717

Trial 6 A2 14.283
A3 10.717
A4 11.783
B1 15.983
B2 16.683
B3 9.700
B4 20.183
C1 19.950

54.57
1

79.000 0.181 5.531

40.81
0
20.717

80.00
0
0.259

59.190

89.000 0.120 8.305

30.61
9
24.283

90.00
0
0.270

69.381

86.000 0.137 7.298

33.66
7
23.217

87.00
0
0.267

66.333

93.000 0.172 5.819

45.66
7
19.017

94.00
0
0.202

54.333

90.000 0.185 5.395

47.66
7
18.317

91.00
0
0.201

52.333

86.000 0.113 8.866

27.71
4
25.300

87.00
0
0.291

72.286

65.000 0.311 3.220

57.66
7
14.817

66.00
0
0.225

42.333

68.000 0.293 3.409

57.00
0
15.050

69.00
0
0.218

43.000

105

C2 8.417
C3 33.133

C4 9.717
infecte
d
A1

79.00
0
0.336

75.952

8.000 4.142 0.241

94.66
7
1.867

9.000 0.207

5.333

85.000 0.114 8.748

27.76
2
25.283

86.00
0
0.294

72.238

72.00
16.350
0 0.227

46.714

18.650 71.000 0.263 3.807

Trial 6 A2 14.150
A3 10.350
A4 11.617
B1 16.300
B2 16.717
B3 10.017
B4 20.400
C1 20.600
C2 8.650
C3 33.283

C4 10.117
Contro
l
A1

78.000 0.108 9.267

24.04
8
26.583

53.28
6

79.000 0.179 5.583

40.42
9
20.850

80.00
0
0.261

59.571

97.000 0.107 9.372

29.57
1
24.650

98.00
0
0.252

70.429

84.000 0.138 7.231

33.19
0
23.383

85.00
0
0.275

66.810

94.000 0.173 5.767

46.57
1
18.700

95.00
0
0.197

53.429

89.000 0.188 5.324

47.76
2
18.283

90.00
0
0.203

52.238

87.000 0.115 8.686

28.61
9
24.983

88.00
0
0.284

71.381

67.000 0.304 3.284

58.28
6
14.600

68.00
0
0.215

41.714

70.000 0.294 3.398

58.85
7
14.400

71.00
0
0.203

41.143

76.000 0.114 8.786

24.71
4
26.350

77.00
0
0.342

75.286

7.000 4.755 0.210

95.09
5
1.717

8.000 0.215

4.905

92.000 0.110 9.094

28.90
5
24.883

93.00
0
0.268

71.095

75.00
16.017
0 0.214

45.760

18.983 74.000 0.257 3.898
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54.24
0

Trial 1 A2 14.383
A3 10.683
A4 11.767
B1 16.400
B2 16.800
B3 10.000
B4 20.383
C1 20.570
C2 8.583
C3 33.167

C4 10.150
High
Fat

A1

78.000 0.184 5.423

41.10
0
20.617

79.00
0
0.261

58.900

99.000 0.108 9.267

30.52
0
24.317

100.0
00
0.243

69.480

86.000 0.137 7.309

33.62
0
23.233

87.00
0
0.267

66.380

94.000 0.174 5.732

46.86
0
18.600

95.00
0
0.196

53.140

89.000 0.189 5.298

48.00
0
18.200

90.00
0
0.202

52.000

87.000 0.115 8.700

28.57
0
25.000

88.00
0
0.284

71.430

66.000 0.309 3.238

58.24
0
14.617

67.00
0
0.218

41.760

69.000 0.298 3.355

58.76
2
14.430

70.00
0
0.206

41.238

77.000 0.111 8.971

24.52
0
26.417

78.00
0
0.339

75.480

9.000 3.685 0.271

94.76
0
1.833

10.00
0
0.183

5.240

91.000 0.112 8.966

29.00
0
24.850

92.00
0
0.270

71.000

53.85
7

73.00
0 0.221

46.143

79.000 0.182 5.486

41.14
3
20.600

80.00
0
0.258

58.857

98.000 0.110 9.116

30.71
4
24.250

99.00
0
0.245

69.286

18.850 72.000 0.262 3.820

Trial 1 A2 14.400
A3 10.750

16.150

33.76
2
A4 11.817

87.000 0.136 7.362
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23.183

88.00
0
0.263

66.238
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